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Following axotomy, the activation of multiple intracellular signaling cascades causes the
expression of a cocktail of regeneration-associated transcription factors which interact with
each other to determine the fate of the injured neurons.The nerve injury response is chan-
neled through manifold and parallel pathways, integrating diverse inputs, and controlling a
complex transcriptional output.Transcription factors form a vital link in the chain of regener-
ation,convertinginjury-inducedstresssignalsintodownstreamproteinexpressionviagene
regulation. They can regulate the intrinsic ability of axons to grow, by controlling expres-
sion of whole cassettes of gene targets. In this review, we have investigated the functional
roles of a number of different transcription factors – c-Jun, activating transcription factor 3,
cAMP response element binding protein, signal transducer, and activator of transcription-3,
CCAAT/enhancer binding proteins β and δ, Oct-6, Sox11, p53, nuclear factor kappa-light-
chain-enhancer of activated B cell, and ELK3 – in peripheral nerve regeneration. Studies
involving use of conditional mutants, microarrays, promoter region mapping, and different
injury paradigms, have enabled us to understand their distinct as well as overlapping roles
in achieving anatomical and functional regeneration after peripheral nerve injury.
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INTRODUCTION
Injury to peripheral nerves elicits a sequence of molecular, cel-
lular, and ultrastructural responses which are vital in triggering
a successful regenerative program associated with neurite out-
growth, re-innervation of the denervated target and recovery of
function.Therapidarrivalof signalsfromtheinjuredaxonresults
in a remarkable shift of the injured neuron from a transmit-
ting to a growth promoting phenotype. This is accomplished by
the upregulation of a vast array of regeneration-associated genes
(RAGs)includingtherapidinductionof transcriptionfactorsand
enhanced synthesis of adhesion molecules, cytoskeletal elements,
growth factors, cytokines, neuropeptides, and other molecules
involved in regeneration.
The molecular changes are accompanied by pronounced mor-
phologicalchangesinthesurvivingneurons–thecellbodyunder-
goes a “chromatolytic” reaction characterized by swelling of the
neuronal body, increase in cellular metabolism and protein syn-
thesis, and a regional dispersion of Nissl bodies in the neuronal
cytoplasm (Lieberman, 1971); and there is a rapid appearance
of growth cones at the proximal tip of the lesioned axons. The
distal nerve stump undergoes “Wallerian degeneration” (Waller,
1850;Dubový,2011),leadingtophagocytosisofaxonalandmyelin
debris by Schwann cells and later also by invading macrophages.
In addition to the neuronal response, neighboring non-
neuronal glial cells – in the case of brain and spinal cord
motoneurons, the astrocytes, and microglia – become activated,
with microglial expression of immune cell recognition molecules
(ICAM1, aMb2, and aXb2 integrins, B7 system, etc.) and major
histocompatibilitycomplex(Werneretal.,1998;Bohatscheketal.,
2004). There is also a rapid microglia-associated recruitment of
lymphocytes within a day after injury which may assist with
immune surveillance ﬁrst in the absence,and later on in the pres-
ence of neuronal cell death (Raivich et al.,1998;Kalla et al.,2001).
In the adult mouse facial motor nucleus model which has been
studied in extensive detail, neuronal cell death is a delayed phe-
nomenon, peaking at 2weeks following nerve transection; the
glioimmune activation is characterized by two phases – a fast
but moderate response starting within 24h after neuronal injury,
and a late but much stronger response to neuronal cell death,
peaking at 14days after axotomy. Neuronal transcription factor
deletions blocking cell death will suppress most of the late glioim-
muneresponse(Raivichetal.,2004;Patodiaetal.,2011).However,
these deletions also inhibit some of the early microglial activa-
tion – within 24h and long before the appearance of cell death,
suggesting that these transcription factors may also interfere with
thesynthesisofinjurysignalsfromlesionedbutnotdyingneurons.
In contrast with the PNS, the CNS neurons normally fail to
regenerate after injury, possibly due to a combination of dimin-
ished intrinsic capacity for regeneration and a heightened sus-
ceptibility to increased inhibitory factors of their extracellular
environment (Maier and Schwab, 2006; Sun et al., 2011). Identi-
fying the crucial elements responsible for successful regeneration
in injured peripheral nerves, and unraveling their underlying sig-
naling pathways and molecular components will be quintessential
in improving regenerative outcomes after peripheral and central
nerve injuries.
Systematic gene expression proﬁling using cDNA microarrays
has led to a dramatic increase in the number of identiﬁed genes
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regulated in the injured and regenerating neurons (Bosse et al.,
2001,2006;Costigan et al.,2002;Kubo et al.,2002;Boeshore et al.,
2004; Kury et al., 2004; Michaelevski et al., 2010). Interestingly,
roughly half of the RAGs are part of both developmental and
lesion-induced programs, suggesting that regeneration partially
recapitulates development. However, this proportion of shared
developmental and lesion-induced transcripts was substantially
lower – only 33% – for genes encoding signal transducers or fac-
tors involved in processes such as cell death, immune response,
transport, and transcriptional regulation. Most of the latter show
injury-speciﬁc gene expression (Bosse et al.,2006).
Transcription factors are DNA binding proteins that can acti-
vateorrepresstargetgeneexpression.Theireffectsareampliﬁedby
their ability to bind to multiple promoter regions, causing a large
number of genes to be switched on or off by a single transcription
factor.Inthisreview,wewillbediscussingthekeymolecularevents
ensuing peripheral nerve injury, focusing on various transcrip-
tion factors that have been implicated to play a role in neuronal
regeneration.
EARLY AXONAL INJURY SENSORS
Axonal injury generates three major signaling cues to the injured
neurons:
A. It interferes with the retrograde ﬂow of trophic signals, disin-
hibiting the normally suppressed regenerative process, within
12–24h following injury (Raivich et al.,1991).
B. It exposes the tip of the injured axons to the intracellular
content of neighboring axons and Schwann cells containing
growth factors like LIF,CNTF,FGF,and NT3 (Elde et al.,1991;
Sendtner et al., 1997; Kirsch et al., 2003), and later to the
inﬂamed neural tissue environment (Lindholm et al., 1987).
The above two processes can result in de novo activated mole-
culescarryinganuclearlocalizationsequence(NLS)whichlink
to importins and are retrogradely transported to the cell body
by dynein motors (Schmied et al.,1993; Hanz et al.,2003).
C. It causes a disruption of the tight ionic concentration gradient
between the axon and the extracellular matrix by rapid inﬂux
of extracellular ions such as calcium and sodium through the
transiently open plasmalemma before it is resealed (Yoo et al.,
2003). This results in depolarization and transmission of suc-
cessiveinjury-mediatedactionpotentials.Thesemolecularand
electrical signals cause rapid elevation of calcium and cAMP,
whichinturnactivatemultipledownstreampathways(Berdan
et al.,1993).
TRANSCRIPTIONAL CHANGES
The arrival of injury signals is rapidly followed by the phos-
phorylation and nuclear localization of a host of transcrip-
tion factors. A brief summary of signaling from early sen-
sors to mostly enzymatic cytoplasmic mediators to transcrip-
tion factors and synthesis of effector molecules is shown in
Figure 1. Data from phospho-proteomic and microarray studies
FIGURE 1 | Cellular signaling in successful regeneration, from early sensors of injury, to cytoplasmic signals, transcription, and downstream effectors
(Modiﬁed Raivich, 2011).
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have identiﬁed nearly 400 redundant axonal signaling networks
connectedto39transcriptionfactors(26transcriptionfactorfam-
ilies), implicated in the sensory neuron response to axonal injury
(Michaelevski et al., 2010). These include c-Jun, Jun D, activating
transcription factor 3 (ATF3), cAMP response element binding
protein (CREB), signal transducer and activator of transcription
(STAT3), CCAAT/enhancer binding proteins (C/EBPs), p53, Oct-
6, nuclear factor kappa-light-chain-enhancer of activated B cells
(NF-κB), nuclear factor of activated T-cells (NFATs), Kruppel-
like factors (KLFs), Sox11, SnoN, ELK3, P311, and E47 among
others (Schwaiger et al., 2000; Mason et al., 2003; Raivich et al.,
2004; Nadeau et al., 2005; Di Giovanni et al., 2006; Jankowski
et al., 2009; Ruff et al., 2009; Magoulas and Lopez-de Heredia,
2010; Moore and Goldberg, 2011; Raivich, 2011). Once in the
nucleus, they bind to selective DNA promoter regions to increase
or repress transcription of speciﬁc target genes. Nerve injury can
also result in reduced activation of transcription factors such as
islet-1, Fra-2, ATF2, and TDP43 (Doyle and Hunt, 1997; Herde-
gen et al., 1997a; Hol et al., 1999; Moisse et al., 2009; Sato et al.,
2009), which probably contributes to the change in gene expres-
sion of the injured neuron from a fully differentiated to a growing
phenotype (Raivich,2011). The activation of transcriptional pro-
gram is critical for expression of many target genes implicated
in successful regeneration, and blocking of transcription at an
early time point after injury changes the regenerative response
of injured neurons (Smith and Skene, 1997). Recent advances
in cre/loxP technology permitting cell-type and/or time spe-
ciﬁc genetic knockouts (Sauer, 1998; Akira, 2000)h a v eb e g u n
to provide insight into the powerful roles of these transcription
factors in orchestrating complex axon growth and regenerative
responses. An overview of the observed phenotypes is given in
Table 1.
C-Jun
The AP-1 transcription complex is a well-characterized regulator
of neural development and consists of homo- or hetero-dimeric
complexes between members of the Jun, c-Fos, and ATF/CREB
families.Aprimarycomponentof theAP-1complex,c-Jun,ispro-
ducedasanimmediateearlygene(IEG)followingnerveinjuryand
persists at high levels in injured neurons during the entire periph-
eralregenerativeprocess(Herdegenetal.,1991;KenneyandKocsis,
1998; Mason et al., 2003; Raivich et al., 2004; Lindwall and Kanje,
2005; Ruff et al., 2009). Schwann cells also strongly upregulate c-
Jun following axotomy, where it functions as a negative regulator
of myelinationandswitchesonlocalinﬂammation(Arthur-Farraj
et al., 2007; Latouche et al., 2009; Wilton et al., 2009). Numerous
studies, using targeted gene deletions or pharmacological inhibi-
tion, have examined the activation, function, and cellular basis
Table 1 |Transcription factor deletions and peripheral nerve regeneration: effects of global (G) and cell-type speciﬁc (cts) knockouts (KO).
Transcription factor
GK Oo rC T SK O
KO phenotype Reference
Neuronal c-Jun (CTS) Strongly reduced target re-innervation Raivich et al. (2004), Makwana et al.
(2010), Ruff et al. (2009) Delayed functional recovery
Decreased RAG expression and neuronal sprouting
Strongly reduced glial activation and leukocyte recruitment
Enhanced motoneuron survival
Cellular atrophy
Schwann cell c-Jun (CTS) Severely impaired axonal regeneration Ruff et al. (2009)
Drastically reduced motoneuron survival
Jun 2A (G) Cellular atrophy Ruff et al. (2009)
Jun 4A (G) Moderately reduced target re-innervation and functional recovery Patodia et al. (unpublished)
Cellular atrophy
ATF3 (G) Enhanced speed of regeneration in mice constitutively expressing ATF3 in DRGs Seijffers et al. (2007)
CREB (G) Impaired axonal/neurite growth Lonze et al. (2002), Lonze and Ginty
(2002), Redmond et al. (2002) Increased apoptosis of sensory neurons
Neuronal STAT3 (CTS) Strongly reduced target re-innervation Bareyre et al. (2011), Patodia et al. (2011)
Delayed functional recovery
Decreased RAG expression and neuronal sprouting
Strongly reduced glial activation and leukocyte recruitment
Enhanced motoneuron survival
Cellular atrophy
C/EBPβ (G) Reduced expression of microtubuleTα1 α tubulin and growth cone protein GAP-43 Nadeau et al. (2005)
C/EBPδ (G) Impaired axonal growth and reduced response to conditioning lesion Magoulas and Lopez-de Heredia (2010),
Patodia et al. (unpublished) Reduced microglial activation
Sox 11 (CTS) Reduced regeneration after nerve crush Jankowski et al. (2009)
p53 (G) Growth cone collapse Di Giovanni et al. (2006),Tedeschi et al.
(2009), Qin et al. (2009) Decreased neurite outgrowth
Reduced target re-innervation
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of c-Jun and suggest a tripartite role of c-Jun action in neural
degeneration, inﬂammation, and repair (Raivich,2008).
Nestin-cre mediated deletion of c-Jun prevented the upreg-
ulation of axotomy-associated molecules (CD44, α7β1 integrin,
galanin).Italsodecreasedperineuronalsprouting(Makwanaetal.,
2010) and successful reconnection to peripheral targets by four to
ﬁvefold, and strongly reduced functional recovery (Raivich et al.,
2004). This massive reduction in target re-innervation was also
observed more than 3months after facial nerve cut, suggesting
that it was a persistent defect, rather than just a delay in the
speed of regeneration. Incidentally, functional recovery did not
appear to require re-innervation of the target by the same num-
ber of neurons. Compared with the Jun-competent littermates,
functional recovery showed a longer but nevertheless transient
delay,suggestingthatlongterm,targetre-innervationbyafraction
of neurons could produce extensive functional recovery (Raivich
et al., 2004). Importantly, though functional recovery is clinically
thecriticalparameter,asolerelianceonthisparametercouldover-
estimate the extent of re-innervation. Non-neuronal responses
like leukocyte recruitment and microglial activation were also
severely compromised in the mutants. Interestingly, the facial
motoneurons in the mutants showed enhanced post-axotomy
survival, but were severely shrunken (Raivich et al., 2004), sup-
porting the previously reported functional dichotomy of c-Jun in
promoting post-traumatic neuronal cell death as well as axonal
regeneration (Herdegen et al., 1997b; Herdegen and Waetzig,
2001).
Because this cre Recombinase was driven by a nestin-promoter
expressed in early neuroepithelial cells giving rise to neurons,
astrocytes,oroligodendrocytes,aswellasSchwanncellsitisraised
the question whether the effects observed in neuronal regenera-
tion were due to the absence of c-Jun in neurons or other nestin+
progenitor-derived cells. This issue was addressed by using trans-
genic mice having neuron-speciﬁc (synapsin promoter controlled
cre-recombination) or Schwann cell-speciﬁc [myelin protein zero
(P0) promoter controlled cre-recombination] c-Jun deletions.
Neuron-speciﬁc c-Jun deletion mirrored the regeneration defect
seen with nestin-cre mediated deletion of c-Jun, i.e., strongly
reduced speed of axonal regeneration, signiﬁcantly delayed func-
tional recovery, strongly reduced target re-innervation, enhanced
motoneuron survival but cellular atrophy and diminished astro-
cyte and microglial activation and T-cell inﬂux (Ruff et al.,
2009). The absence of c-Jun in Schwann cells also caused severely
impairedaxonalregeneration.However,itstronglyincreasedneu-
ronal cell death after nerve injury (Ruff et al.,2009). These results
suggest a critical role of both Schwann cell and neuronal c-Jun
in the axonal injury response, which led to the next challenge
of understanding the mechanisms underlying its activation and
signaling following axonal injury.
Activation of c-Jun mediated transcription is affected by inter-
actionsatthreemajorsites:N-terminalphosphorylationatserines
63 and 73 and threonines 91 and 93 by the Jun N-terminal kinases
(JNKs) and the ensuing ubiquitination and degradation, dephos-
phorylation of Thr239, and C-terminal lysine acetylation near aa
257–276 (Vries et al., 2001; Morton et al., 2003). The JNKs are
rapidly activated following peripheral nerve injury, and are ret-
rogradely transported to the cell body along with the upstream
kinases MEKK1 and p-MKK4, as well as the JNK interacting pro-
tein(JIP),ascaffoldproteinthatstabilizestheinteractionbetween
JNKanditsupstreamkinases(LindwallandKanje,2005),reviewed
in Raivich (2008). Neuronal injury increases JNK-mediated c-Jun
phosphorylation(Herdegenetal.,1998;KenneyandKocsis,1998),
and application of a JNK inhibitor to explants of injured DRGs
reduces c-Jun phosphorylation, ATF3 expression, and neurite
outgrowth, without affecting survival (Lindwall et al.,2004).
Removal of Ser63 and 73 phosphoacceptor sites in the JunAA
mutant interfered with kainic acid excitotoxicity in hippocam-
pal neurons (Behrens et al., 1999) at levels similar to JNK3 KO
(Brecht et al., 2005), identifying c-Jun as an essential substrate of
JNK signaling during kainate-induced neuronal apoptosis. While
global c-Jun deletion is embryonically lethal,JunAA mice showed
normal development (albeit slightly smaller than littermate wild-
type mice) and were fertile (Behrens et al.,1999). Following optic
nerve transection, there was a partial but signiﬁcant reduction of
the apoptosis of retinal ganglion cells in JunAA mice, and Fas L
has been suggested to be an important target gene regulated by
N-terminal Jun phosphorylation during apoptosis (Yoshida et al.,
2002).JunAAandJNK3nullmutantsalsoshowedbetterneuronal
survivalaftertargeteddopaminergiccelldeath(Brechtetal.,2005;
Crocker et al.,2006). Trophic factor deprivation or DNA damage-
induced death was signiﬁcantly delayed in JunAA neurons which
correlated with delayed expression of pro-apoptotic genes (Besirli
et al., 2005). In contrast, the JNK3 KO or JunAA mutations did
not interfere with neuronal cell death after facial axotomy (Brecht
et al., 2005; Ruff et al., 2009). This difference could be attributed
to the fact that facial axotomy affects peripheral neurons, unlike
previousstudieswhichdiscusseffectsofphosphorylationdeﬁcient
c-Jun on apoptosis of CNS neurons.
Preliminary studies from our group after facial axotomy
revealed that JunAA mice do show some neuronal shrinkage, but
have no effect on speed of axonal regeneration for fastest axons,
functional recovery, or target re-innervation (Ruff et al., 2009).
Deletion of JNK1 or JNK3 single genes showed somewhat delayed
functional recovery after facial nerve axotomy but the effects were
quite moderate; and deletion of JNK2 had no effect on regenera-
tion (Ruff et al.,2009). The mild effects of JunAA and global JNK
deletions, and the fact that JNKs can act via c-Jun independent
cytoplasmic (stathmin, MAP1b, MAP2) and nuclear (e.g., ATF2,
ELK1, p53, etc.) targets (Björkblom et al., 2005; Bogoyevitch and
Kobe, 2006; Barnat et al., 2010; Westerlund et al., 2011), points to
a possible parting of ways: i.e., the observed JNK null effects on
regenerationarec-Junindependent,andthestrongJun-dependent
effects on regeneration and survival do not require N-terminal
phosphorylation. Recent studies using Jun4A mice where all four
JNK dependent N-terminal phosphorylation sites – Thr91 and 93
as well as Ser63 and 73 – are removed (Patodia et al.,unpublished
observations) partially conﬁrm this notion. The Jun4A mutation
does not interfere with the expression of injury-associated neu-
ronal and non-neuronal markers. On the other hand, as in the
JNK1 and 3 null mutants, the Jun4A strain reproduces the mod-
erate reduction in functional recovery and a 40% lower number
of reinnervating motoneurons at 28days following facial nerve
cut. However, this effect on regeneration is considerably smaller
than that observed for neuronal c-Jun deletion, suggesting that
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the regeneration effect of c-Jun is mostly independent of its N-
terminal phosphorylation. At present, no information is available
with regards to the regeneration-associated Jun effects of Thr239
dephosphorylation, or for C-terminal acetylation.
ACTIVATING TRANSCRIPTION FACTOR 3
Activating transcription factor 3 is a member of the ATF/CREB
familyofbasicleucinezipperdomain(bZIP)transcriptionfactors.
It can form homo- or hetero-dimers with other bZIP transcrip-
tion factors like members of the AP-1 family (ATF2, JunB, JunD,
c-Jun,c-fos)andc/EBPs(HaiandCurran,1991;HaiandHartman,
2001). ATF3 is normally expressed at low levels, but is rapidly
activated in sensory, sympathetic, and motor neurons by stress
stimuli after peripheral nerve injury (Tsujino et al., 2000; Raivich
and Behrens, 2006; Hyatt Sachs et al., 2007; Zigmond and Vac-
cariello, 2007), optic nerve injury (Takeda et al., 2000), and NGF
depletion (Mayumi-Matsuda et al., 1999) but not after central
injury (Tsujino et al., 2000). ATF3 expression is also induced in
the disconnected Schwann cells and endoneurial ﬁbroblasts distal
totheperipheralinjurysite,thoughnotoncentral,denervatedglia
(Hunt et al.,2004). Several pathways have been implicated in acti-
vating ATF3 expression such as neurotrophin deprivation (Hyatt
Sachsetal.,2007),aswellasJNK/SAPKandp53-dependentmech-
anisms(MooreandGoldberg,2011).ATF3isaxonallytransported
from the periphery (Lindwall and Kanje,2005),possibly acting as
a retrograde signal.
DeliveryofATF3toadultDRGneurons,neonatalSCGneurons
and PC12 cells, enhanced both the number of neurons extend-
ing neurites and neurite length (Nakagomi et al., 2003; Pearson
et al., 2003; Seijffers et al., 2006). As after conditioning peripheral
injury,thepatternof growthconsistedof longneuritesratherthan
branchedarborizedones(Seijffersetal.,2007).Intransgenicmice
constitutively expressing ATF3 in adult DRGs, the rate of periph-
eral nerve regeneration (measured by the nerve pinch test 2days
aftersciaticnervecrush)wasenhancedtoanextentcomparableto
that produced by a preconditioning lesion (Seijffers et al., 2007).
The expression of some growth-associated genes, such as Hsp27,
SPRR1A, and c-Jun was increased in the non-injured neurons,
but not of others like the alpha 7 integrin subunit (α7), GAP-
43, CAP23, and STAT3. Unlike peripheral nerve-conditioning
lesions, ATF3 overexpression also did not overcome the inhibi-
tion produced by CNS myelin in culture, suggesting the mecha-
nisms responsible for axonal regeneration are separate from those
involved in overcoming glial-associated inhibition (Seijffers et al.,
2007).
Activatingtranscriptionfactor3canbinddirectlytotheHsp27
promoterandactivateitsexpressioninPC12cells(Nakagomietal.,
2003). In addition to its role as an injury-induced neuronal sur-
vival factor, Hsp27 enhances neurite outgrowth in cultured adult
DRGneurons(Williamsetal.,2006),possiblyasaresultofinterac-
tions with the cytoskeleton. The growth-associated gene SPRR1A
promotes axonal outgrowth by interacting with actin structures
(Bonillaetal.,2002)andATF3mayregulateitsexpressioneitherby
bindingdirectlytoitspromoterorbyaffectingothertranscription
factors.ATF3 also appears to have a survival role,preventing JNK-
mediated neuronal death (Nakagomi et al.,2003). Thus,although
ATF3 appears to contribute to nerve regeneration by increasing
the intrinsic growth state of injured neurons, its upregulation is
not enough to fully recapitulate the peripheral nerve regeneration
program (Seijffers et al., 2007).
Activating transcription factor 3 can form hetero-dimers with
c-Jun, leading to enhanced transcriptional activation of various
RAGs and increased neurite outgrowth in neuronal cell lines (Hai
and Curran, 1991; Hai and Hartman, 2001; Pearson et al., 2003).
There has been a number of conﬂicting reports regarding the cor-
relation between increased ATF3 expression and upregulation of
c-Jun in surviving neurons. In 2003, Pearson et al., showed that
in the absence of c-Jun,ATF3 failed to enhance neurite outgrowth
in PC12 cells, suggesting that a coincident presence of c-Jun and
ATF3mayactsynergistically(possiblyviaaphysicalinteraction)to
promote nerve regeneration (Pearson et al., 2003; Lindwall et al.,
2004). In contrast,Seijffers et al. (2006) showed enhanced neurite
outgrowth in adult DRG neurons by ATF3 without any increase
in endogenous c-Jun levels. The scope of c-Jun and ATF3 expres-
sion in DRG neurons after sciatic nerve transection also differs:
ATF3isinducedinallinjuredneurons,phosphorylatedc-Junonly
in a small subset of mostly small and medium sized DRG neu-
rons(KenneyandKocsis,1998;Tsujinoetal.,2000;Lindwalletal.,
2004). Sciatic nerve injury induces prolonged activation of JNKs
in the DRGs (Kenney and Kocsis, 1998). Inhibiting JNK in this
model led to decreased activation of c-Jun and ATF3 expression,
and to decreased axonal growth (Lindwall et al., 2004). Recent
results from our group show that deletion of neuronal c-Jun or
STAT3 interferes with the nuclear transfer of ATF3 in the axo-
tomizedfacialmotorneurons(PatodiaandRaivich,unpublished).
Thiseffectmaybespeciﬁcformotoneurons–insympatheticneu-
rons,cell-speciﬁcdeletionof gp130interfereswiththeappearance
of phosphorylated nuclear STAT3, but does not affect the nuclear
translocation of ATF3 (Habecker et al., 2009). Thus, the extent to
which the growth promoting action of ATF3 is autonomous of c-
Jun and STAT3 and dependent on additional injury signals needs
to be explored.
cAMP RESPONSE ELEMENT BINDING PROTEIN
TheCREBisamemberoftheATF/CREBfamilyofbZIPtranscrip-
tionfactors(HaiandHartman,2001),andmediatescAMPsignal-
ing in the nervous system by forming homo- or hetero-dimers
with other bZIP factors (Hannila and Filbin, 2008). The brains
of CREB null mice show abnormal development of the corpus
callosum and anterior commissure (Rudolph et al., 1998). CREB
can be phosphorylated and activated by many kinases, including
PKA,PKC,CAMKII,CAMKIV,AKT,MAPKAP K2,and members
of RSK and MSK families (Mayr and Montminy, 2001), and it is
negatively regulated by phosphatases such as PP1 and PP2A (Sun
et al., 1994). Important targets of CREB include arginase I and
BDNF (Mayr and Montminy, 2001; Cai et al., 2002; Deng et al.,
2009).
In vitro cultured DRG and SCG neurons from CREB null mice
show shorter neurites than controls. In vivo, these mutant mice
exhibit impaired axonal growth and projections. Their sensory
neurons undergo excess apoptosis and degeneration during the
period of NGF dependency in the absence of CREB (Lonze and
Ginty, 2002; Lonze et al., 2002). In addition, overexpression of a
dominant negative CREB leads to decreased dendritic outgrowth
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in cortical neurons and loss of cAMP or neurotrophin associated
neurite outgrowth on an inhibitory substrate (Redmond et al.,
2002). This suggests an important role for CREB-mediated gene
expression for both survival and axonal growth in PNS neurons.
Recently, it has been suggested that axonal translation of CREB
mRNAs may precede its phosphorylation, nuclear translocation,
and transcriptional activation of pro-survival genes (Cox et al.,
2008).
SIGNAL TRANSDUCER AND ACTIVATOR OF
TRANSCRIPTION-3
Signal transducer and activator of transcription-3 belongs to the
STATfamilyofseventranscriptionfactors–STAT1,STAT2,STAT3,
STAT4, STAT5a, STAT5b, and STAT6 – that mediate a wide vari-
ety of biological functions in the CNS and PNS such as cell
growth, regulation, inﬂammation, and embryological develop-
ment (Dziennis and Alkayed, 2008). The STATs are comprised
of six regular domains – an amino terminal (for STAT3 dimer-
ization after activation), coiled-coil domain (for interaction with
othertranscriptionfactorsandregulatoryproteins),DNAbinding
domainmadeupofβ-sheets(forrecognitionofconsensusbinding
r e g i o n so ng e n ep r o m o t e r s ) ,α-helical linker domain (for tran-
scriptional activation and protein–protein interaction),a classical
SH2 (sequence – homology) docking domain, and a transcrip-
tional activation domain (Bromberg and Darnell, 2000; Lim and
Cao, 2006). There are two highly conserved, phosphorylatable
amino acids that are frequently required for STAT3 activation – a
tyrosine 705 in the SH2 domain and a serine 727 in the 78-amino
acidregionof thetransactivationdomain(BrombergandDarnell,
2000; Dziennis and Alkayed, 2008).
Injury-induced ligand binding to cell-surface receptors acti-
vates the associated receptor tyrosine kinase Janus kinases (JAKs),
which phosphorylate tyrosine residues on the cytoplasmic por-
tion of the receptor complex that acts as a binding site for
STAT proteins. STATs dock onto the phospho-tyrosines via their
SH2 domain, and are also phosphorylated by JAK on a tyrosine
residue(e.g.,Y705inSTAT3).Uponactivation,theyeitherhetero-
or homodimerize and translocate to the nucleus via importins
(Cimica et al., 2011), where they bind to consensus sequences
(SIE/GAS/ISRE sequences) to induce gene transcription. Other
mechanisms of STAT activation include phosphorylation by non-
receptortyrosinekinasessuchasSrc,direct,orindirectphosphory-
lationbyreceptorswithintrinsictyrosinekinaseactivity(i.e.,EGF,
PDGF, and FGF receptors), and activation by G-protein coupled
receptors (Ram and Iyengar, 2001). STAT3 can be deactivated by
dephosphorylation or targeted degradation, and recycled back to
the cytosol (reviewed by Lim and Cao, 2006; Dziennis and Alka-
yed, 2008; Moore and Goldberg, 2011). Further, Suppressor of
Cytokine Signaling 3 (SOCS3) or protein inhibitors of activated
STATS(PIAS)canalsoinhibitSTAT3activation(KrebsandHilton,
2001).
In the adult brain, STATs are normally quiescent, but are acti-
vated following injury in response to multiple signaling path-
ways induced by several cytokines and growth factors includ-
ing IL-6, LIF, CNTF, G-CSF, G-CSFR, EPO, EGF, IGF-1, NGF
withdrawal, BDNF, free radicals, excitatory neurotransmitters
and other inﬂammatory mediators that are released after injury
(reviewed in Dziennis and Alkayed, 2008). Propagation of many
of these signals (IL-6, LIF, and CNTF) requires a combination of
various ligand binding units and a common signal-transducing
unit gp130 (Taga and Kishimoto, 1995), through which they
activate the JAK/STAT, Ras/MAPK, extracellular regulated-signal
kinase (ERK), PI3K, and other pathways (Akira, 2000; Heinrich
et al.,2003).Activation of the gp130-receptor has been implicated
in neuronal response to injury and regenerative axonal growth
(Habecker et al., 2009; Hyatt Sachs et al.,2010).
Signal transducer and activator of transcription-3 was identi-
ﬁed as an acute phase response factor (Akira et al., 1994) and is
expressed cytoplasmically in both neuronal and glial cells during
developmentandintheadult(De-Frajaetal.,1998;Gautronetal.,
2006). Nervous system insult leads to STAT3 activation in speciﬁc
subsetsof neuronswiththepatternof activationdependentonthe
natureof theinsult(Schwaigeretal.,2000;Xiaetal.,2002).Global
STAT3 knockout animals are embryonic lethal,dying prior to gas-
trulation between E6.5 and 7.5 (Takeda et al., 1997). Cell-type
speciﬁc STAT3 deletion has greatly improved our knowledge of
its function in different tissues (Sauer, 1998; Akira, 2000). STAT3
deletion in T-cells is associated with impaired T-cell proliferation,
in macrophages with high susceptibility to endotoxin shock, in
keratinocytes with compromised wound healing process, and in
mammary glands with delay of involution (Akira, 2000). Nestin-
promoter mediated neural-speciﬁc disruption of STAT3 resulted
inmicewhichwerehyperphagic,obese,diabetic,andinfertile(Gao
et al.,2004).
In the last decade, there has been growing evidence of a role
of STAT3 in axonal regeneration. In vitro, STAT3 induces neu-
rite growth in motor and sensory neurons and this growth can be
inhibitedbytheapplicationof SOCS3(LiuandSnider,2001;Miao
et al., 2006). STAT3 induces GAP-43, a protein found in growth
cones, and GAP-43 expression is inhibited with the JAK inhibitor
AG-490, suggesting a role for the JAK/STAT3 pathway in GAP-
43 expression and neurite outgrowth and regeneration (Wu and
Bradshaw,1996).
Haas et al. (1999) observed STAT3 activation at 24h and
5days after rat facial nerve axotomy. Following rat facial and
hypoglossal nerve axotomy, a transient but signiﬁcant increase
in STAT3 mRNA, along with its phosphorylation and nuclear
translocation within 3h in neurons and 1day in astrocytes was
observedbySchwaigeretal.(2000).Incontrast,thesechangeswere
not observed in non-regenerating neurons of Clarke’s nucleus,
although both forms of injury upregulated c-Jun and GAP-43
expression (Schwaiger et al., 2000). Transient increases in STAT3
signaling were also found in sprouting neurites and astrocytes
following entorhinal cortex lesions in addition to a rise in gp130-
receptor cytokines, suggesting a dual role of STAT3 in both astro-
cytic regulation and axonal sprouting (Xia et al., 2002). L e ee ta l .
(2004) showed that axonal STAT3,activated at the injury site,acts
as both a retrograde injury signal and as a transcription factor
which promotes the survival and regeneration of both sensory
and motor neurons. Levels of activated STAT3 increased in the
nuclei of regenerating adult cranial motor neurons, sciatic motor
neurons and in sensory neuron nuclei after injury. Sciatic nerve
lesionledtoaveryrapidactivationof STAT3inaxonsatthelesion
site within 15min, and by 24h STAT3 labeling was detected in
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the DRG and in the spinal cord (Lee et al., 2004). These levels of
STAT3 decreased when regeneration was completed,emphasizing
its role in the regenerative process.
Deletion of CNTF,which is abundantly present in myelinating
Schwann cells but not in or around the cell bodies of axotomized
motoneurons (Dobrea et al., 1992; Rende et al., 1992) caused a
delay in the appearance of phosphorylated STAT3 and its nuclear
translocation in neuronal cell bodies (Kirsch et al., 2003). This
delay points to a signaling cascade beginning with local release
of CNTF by damaged myelinating Schwann cells, its local action
on adjacent axons, intra-axonal phosphorylation of STAT3 and
its retrograde transport to the cell bodies of injured neurons and
ﬁnally to the nucleus. Recent studies using repetitive in vivo imag-
ing of individual ﬂuorescently labeled axons have shown that
STAT3 selectively regulates initiation but not later perpetuation
of axonal growth, thus acting as a phase-speciﬁc regulator of
axonal outgrowth in both PNS and CNS (Bareyre et al., 2011).
Altogether, these studies show a general trend of early and persis-
tent expression of phosphorylated STAT3 during the regenerative
process.
A number of in vitro and in vivo studies have also implicated
the role of STAT3 as an intracellular survival-promoting factor.
In vitro studies using cell lines have shown that STAT3 expression
directlyinducesbcl-2 andbcl-xL geneexpression,whicharecritical
in promoting neuronal survival after injury (Dziennis and Alka-
yed, 2008). Mice lacking STAT3 in facial and spinal motoneurons
(controlledbycreexpressionunderNF-Lpromoter)showedasig-
niﬁcantreductioninmotoneuronsurvivalafterfacialnervelesion,
which closely correlated with the extent of motoneuron loss seen
in LIF/CNTF KO mice after nerve lesion (Sendtner et al., 1996;
Schweizer et al., 2002). Moreover, upregulation of Reg-2 and Bcl-
xl expression was reduced in axotomized motoneurons in STAT3
KO mice, suggesting a role of STAT3 in anti-apoptotic signaling.
Interestingly, in the study by Schweizer et al. (2002) local appli-
cation of CNTF strongly reduced the apparent motoneuron cell
deathintheabsenceof neuronalSTAT3,butwhichothersignaling
pathways were involved is unclear.
Preliminary data from our lab suggests an important role for
neuronal STAT3 in axonal regeneration (Patodia et al., 2011).
Conditional mice mutants, lacking STAT3 in their neurons, had
profound defects in the usual retrograde response, with a severe
early and persistent reduction by 75–90% in microglial activation
and recruitment of lymphocytes, and 4days after injury in speed
of axonal elongation in the distal stump. At 30days, axotomized
STAT3-deﬁcient motoneurons appeared shrunk by 50–60% in
size but displayed no cell death in contrast to results published
earlier (Schweizer et al., 2002). Functional recovery was dramat-
ically reduced and the mutants showed 80% less target muscle
re-innervation. As with neuronal c-Jun deletion which interferes
with regeneration (Raivich et al., 2004), expression of RAGs like
CD44, β1 integrin, CGRP, galanin as well as the nuclear translo-
cation of ATF3 was also greatly diminished or abolished in the
STAT3 mutants. However,c-Jun expression itself was not affected,
suggesting that deletion of either transcription factor – c-Jun
or STAT3 – will produce a very similar regeneration-deﬁcient
phenotype.
CCAAT/ENHANCER BINDING PROTEIN β, δ
TheC/EBPfamilyof transcriptionfactorsiscomprisedof sixpro-
teins (C/EBPα, β, γ, δ, ε, and ζ), each having unique properties
regulating cellular proliferation and differentiation, particularly
in hepatocytes, adipocytes, and hematopoietic cells (Ramji and
Foka,2002). C/EBPs also play pivotal,non-redundant roles in the
development and plasticity of the nervous system, including cell
fate determination, apoptosis, synthesis and response to trophic
factors and responses to brain injury and ischemia (Kfoury and
Kapatos, 2009). All members have a DNA binding domain and
a highly homologous bZIP domain which is required for dimer-
ization. The C/EBPs can interact with other bZIP and non-bZIP
transcription factors (Huang et al.,2007).
CCAAT/enhancer binding protein-δ (also known as CELF,
CRP3, and NF/IL-6) expression is typically low to undetectable
in most cell-types and tissues, but it is rapidly induced by a vari-
ety of extracellular stimuli (e.g., growth hormone, insulin, IFNγ,
IL-1, IL-6, LPS, TNFα, noradrenaline, and glutamate), phospho-
rylated, and translocated to the nucleus as an active transcription
factor where is induces further IL-6 expression (Ramji and Foka,
2002). The most favorable complex responsible for the transcrip-
tion of the IL-6 gene requires the interaction between p65 and
C/EBPδ, with c-Jun occurring on the NF-κB site (Faggioli et al.,
2004). C/EBPδ is elevated in hypoxia,glaucoma,carcinoma,trau-
maticbraininjuryandinthebrainsofAlzheimer’sdiseasepatients
(Huang et al., 2007;Yang et al., 2007). A recent study showed that
the anti-inﬂammatory and neuroprotective effects of chrysin on
reactive microglial cell induced neurotoxicity was partly medi-
ated by inhibition of C/EBPδ expression at both protein and
mRNA levels. C/EBPδ-deﬁcient microglial cultures produce less
NO and TNFα in response to LPS/IFNγ, re-afﬁrming its role
in microglial activation and neuroinﬂammation (Gresa-Arribas
et al., 2010). C/EBPβδ double knockout in mouse embryonic
ﬁbroblasts showed particularly impaired production of IL-6 and
TNFα in response to LPS or IL-1, suggesting complementary
roles of C/EBPβ and C/EBPδ in induction of proinﬂammatory
cytokines (Ramji and Foka,2002).
CCAAT/enhancer binding protein β is upregulated and phos-
phorylated across different classes of injured neurons, including
the invertebrate Aplysia model. In this model,phosphorylation of
Aplysia C/EBPβ is mediated by the RISK1, a mitogen associated
protein kinase homolog related to the ERK family (Sung et al.,
2001). In the mouse facial nerve model, C/EBPβ is important
for the expression of regeneration-associated microtubule Tα1 α
tubulinandgrowthconeproteinGAP-43,suggestingthatC/EBPβ
isacriticalcomponentof theregenerativeresponse(Nadeauetal.,
2005).
In the case of C/EPBδ, which is upregulated in sensory and
sympathetic neurons (Boeshore et al.,2004;Magoulas and Lopez-
de Heredia, 2010), initial studies using cultured primary sensory
neurons from C/EPBδ null mice show impaired axonal growth
and a reduced response to the conditioning lesion (Magoulas and
Lopez-deHeredia,2010).Preliminaryresultsfromourstudiesalso
conﬁrmthisﬁndinginthemotor,facialnerveinjurymodelaswell
asindicatearoleforC/EBPδinearlyandlatemicroglialactivation
(Patodia et al.,unpublished).
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In summary, a number of intriguing ﬁndings implicate a role
of C/EBPsininjuryresponseinneurons,i.e.,theyaremediatorsof
neuro-inﬂammatoryresponsesinthebrain;areinducedininjured
neurons of invertebrates (Korneev et al., 1997; Sung et al., 2001)
as well as vertebrates (Nadeau et al., 2005); have RAGs like Tα1
α tubulin and GAP-43 as direct transcriptional targets (Nadeau
etal.,2005);andareupregulatedbyIL-6,animportantpost-injury
molecule (Ramji et al., 1993). A number of alternative signaling
pathways might also converge onto C/EBP family members fol-
lowing axonal injury,e.g.,the JAK–STAT pathway has been shown
to directly regulate C/EBPβ (Jiang and Zarnegar,1997).
Oct-6
Transcription factors Oct-6 (SCIP/Tst-1), Krox-20 (Egr-2), and
Sox 10 are major regulators of Schwann cell differentiation and
myelination (Topilko et al., 1994; Bermingham et al., 1996; Jaegle
and Meijer, 1998). A fragment distal to the Oct-6 gene, con-
taining two DNase I-hypersensitive sites, acts as the Schwann
cell-speciﬁc enhancer (SCE) and is responsible for the complex
signaling between Schwann cells and axons driving myelination,
during both normal peripheral nerve development and regenera-
tion(Mandemakersetal.,2000).Oct-6ispresentinthecytoplasm
ofSchwanncellsassociatedwithmyelinatedﬁbersofintactnerves.
Axonal injury induces nuclear Oct-6 expression during the acute
degenerative stage, reaching peak expression levels in the subse-
quentregenerativestage(Schereretal.,1994;Kawasakietal.,2003),
suggesting that at the time of regeneration, Oct-6 is translocated
to the nucleus to promote transcription of genes, possibly those
encoding myelin proteins. Oct-6 expression is down-regulated in
fully regenerated nerves and in nerves showing chronic axonal
loss (Kawasaki et al., 2003). Therefore, Oct-6 may be a marker
for dedifferentiation of adult Schwann cells and active nerve
regeneration.
Sox11
SRY-box containing gene 11 (Sox11), a member of the Sox tran-
scription factor family, is highly expressed in developing sensory
neurons and at low levels in adult neurons (Jankowski et al.,2006;
MooreandGoldberg,2011).TherehasbeenlimitedstudyofSox11
targets in axonal growth,but Sox11 can partner with Brn1 or -2 to
regulate transcription (Kuhlbrodt et al.,1998; Tanaka et al.,2004)
and drive expression of neurite growth-associated genes like β-III
tubulin, MAP2 (Bergsland et al., 2006) and actin-related protein
complex 3 (Arpc3; Jankowski et al., 2006). Sox11 expression in
sensory and sympathetic ganglia is highly sensitive to nerve cut
and crush injuries, rising steadily after injury and during subse-
quent regeneration, and returning to baseline levels at the end of
regeneration (Boeshore et al., 2004; Jankowski et al., 2006, 2009).
In Neuro2a cells, Sox11 levels dramatically increased with the
number of cells extending neurites. In vitro experiments using
cultured adult DRG neurons treated with Sox11 siRNAs exhibit
a signiﬁcant decrease in regeneration following axotomy as indi-
cated by reduced neurite length and branching index (Jankowski
etal.,2006).ThissuggestsacorrelationbetweenSox11andneurite
growth.
Injection of Sox11 siRNAs into mouse saphenous nerve caused
atransientknockdownof Sox11mRNA,thattransientlyinhibited
in vivo regenerationafternervecrush.Electronmicroscopyanaly-
sis of Sox11 RNAi-injected nerves showed that regeneration of
both myelinated and unmyelinated axons was inhibited. Nearly
all neurons in the ganglia of crushed nerves that were Sox11
immunopositive showed co-labeling for ATF3 (Jankowski et al.,
2009)andtreatmentwithSox11siRNAsinvitro andinvivo caused
atranscriptionalandtranslationallevelreductioninATF3expres-
sion.Interestingly,ATF3ablationusingATF3siRNAsdidnotaffect
Sox11 levels,suggesting that Sox11 may act upstream of ATF3 and
inﬂuenceregulationof itsgeneexpression(Jankowskietal.,2009).
Theseanatomicalandexpressiondatasupportanintrinsicrolefor
Sox11 in axonal regeneration that may involve interaction with
ATF3.
p53
p53 is a member of a family of tumor suppressors together with
p63 and p73. Like c-Jun, p53 is known to mediate both pro- and
anti-apoptotic roles in the nervous system (Culmsee and Matt-
son, 2005; Jacobs et al., 2006). p53 can undergo multiple types of
post-translational modiﬁcations including acetylation, phospho-
rylation, and ubiquitination, which can affect its localization and
function (Lavin and Gueven, 2006; Tedeschi et al., 2009). In vitro
and in vivo experiments have shown that p53 plays a role in pro-
moting neurite growth. Overexpression of a dominant negative
form of p53 in primary cortical neurons leads to growth cone
collapse and decrease in neurite outgrowth, possibly due to a
combination of reduced expression of its growth cone associated
target genes Coronin1b, Rab13, and GAP-43 (Di Giovanni et al.,
2006;Tedeschietal.,2009),aswellasitslocal,non-transcriptional
activity at the growth cone (Qin et al., 2009). On the other hand,
overexpression of wild-type p53 leads to an increase in growth
cone size (Qin et al.,2009). Other axonal guidance molecules and
theirreceptorslikenetrins,semaphorins,andephrinsarealsoreg-
ulated by p53 (Arakawa, 2005). In vivo experiments using p53
knockout mice showed a signiﬁcant decrease in the number of
ﬁbers reinnervating the target muscles at 28days after facial axo-
tomyinthemutantmicewhencomparedwithcontrolanimals(Di
Giovanni et al., 2006). Taken together, these studies suggest a role
for p53 in modulating neurite growth and regeneration. Given its
welldescribedroleinapoptosisofneuronsandnon-neuronalcells,
it will be interesting to investigate its effects on neuronal survival
after peripheral nerve injury.
NUCLEAR FACTOR KAPPA-LIGHT-CHAIN-ENHANCER OF
ACTIVATED B CELLS
Nuclear factor kappa-light-chain-enhancer of activated B cells is
an inducible transcription factor dimer made up of 5 subunits,
boundashomo-orhetero-dimers:RelA/p65,c-Rel,RelB,p50,and
p52. Inhibitor of κB( I κβ) family of proteins can bind to NF-κB
dimer and prevent its nuclear translocation. Dissociation or pro-
teasomal degradation of IκB reveals NF-κB’s nuclear localization
sequence (NLS), allowing it to move to the nucleus and mod-
ulate gene transcription by binding to promoter and enhancer
sequences (reviewed by Moore and Goldberg, 2011).
Nuclear factor kappa-light-chain-enhancer of activated B cells
is signiﬁcantly upregulated in DRGs and spinal cord after periph-
eral nerve crush (Ma and Bisby, 1998; Pollock et al., 2005). It can
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r e s p o n dt oas t i m u l u si nn e u r i t e sa n dr e t r o g r a d e l yt r a v e lt ot h e
nucleus to affect gene transcription. NF-κB signaling can either
enhance of inhibit neurite growth depending on the phosphory-
lation status of its RelA/p65 subunit. Phosphorylation of p65 by
IKKβ results in reduced neurite growth, and in neurons without
this IKKβ activity, there is increased neurite growth (Gutierrez
et al., 2008). Identiﬁed neuronal targets of NF-κB include genes
for Bcl-2, MnSOD, glutamate receptor subunits, BDNF, and cal-
ciumregulatingproteins(reviewedbyMattson,2005).Inaddition,
NF-κB has been shown to regulate expression of cell-adhesion
moleculeslikeNCAM,tenascinCandβ1integrininothersystems
(reviewedbyMooreandGoldberg,2011).NF-κBisalsothedown-
stream modulator of neurite growth for fas apoptosis inhibitory
molecule (FAIM) signaling. Blocking NF-κB activation prevents
the increase of neurite growth seen with FAIM overexpression
(Sole et al.,2004).
ELK
The ETS-like (ELK) subfamily of transcription factors comprises
of ELK1,ELK3,and ELK4 factors which can have different poten-
tial protein–protein interactions, and respond differently to MAP
kinase signaling pathways (Ducret et al., 2000; Buchwalter et al.,
2004). Seven days after peripheral axotomy, a 2.3-fold upregu-
lation of ELK3 mRNA, but not of ELK1 or ELK4 mRNA was
detected in adult mouse DRGs (Kerr et al., 2010). The expression
of neuropeptide galanin mRNA is upregulated around 80-fold
in DRGs following axotomy, and an 18bp sequence within its
promoter/enhancer region containing overlapping putative ETS,
STAT, and Smad binding sites, has been shown to be critical for
this response (Bacon et al., 2007), making ELK3 a potentially
important player in peripheral nerve regeneration. It would be
interesting to see if the injury-induced ELK3 isoforms can dif-
ferently affect neuronal survival and/or regeneration after axonal
injury.
CROSS-TALK BETWEEN TRANSCRIPTION FACTORS
Transcriptionfactorsformanintricatenetworkinwhichcross-talk
between different pathways leads to an integrated and input-
balanced signaling outcome (Morrison and Davis, 2003; Moore
and Goldberg,2011). Some axonal regeneration still occurs in the
absence of master regulators of regeneration like c-Jun,highlight-
ingtheexistenceofalternativepathways,andofcompensatoryand
complementary/synergistic mechanisms, which may be shared
during axonal outgrowth.
Jun N-terminal kinase signaling is interconnected with various
othercellularsignalingpathways,suchasNFkBandtheJAK/STAT
system (Waetzig et al., 2006; Haeusgen et al., 2009), resulting in
STAT3 phosphorylation (Levy and Lee, 2002). Besides JNK, c-Jun
can also be activated by ERK1/2 (Leppa et al.,1998; Schwarz et al.,
2002; Morton et al., 2003). On the other hand, STAT3 can stimu-
latetranscriptionof severalAP-1membersincludingJunB(Coffer
etal.,1995)andc-fos(Yangetal.,2003;Higashietal.,2004)which
have STAT3 responsive elements in their regulatory sequence.
The interactions between AP-1 and STAT3 are multiple and
complex, resulting in mutual modulation of their transcriptional
activities. STAT3 and AP-1 factors can bind to independent but
closely spaced DNA binding sites in the regulatory sequences of
a number of genes, such as α-2 macroglobulin (Schaefer et al.,
1995), VIP (Symes et al., 1997), bcl-6 (Arguni et al., 2006), and
matrix metallo-proteinases and synergistically induce maximal
enhancer function (Zhang et al., 1999). AP-1 complexes can also
binddirectlytoSTAT3,enhancingSTAT3’stranscriptionalactivity
(Schaefer et al., 1995; Leu et al., 2001). Mapping of the STAT3–c-
JuninteractiveregionsbyGSTpull-downassayssuggestedthatthe
STAT3-interactive region lies within its coiled-coiled domain,and
in a portion of the DNA binding domain. The c-Jun interactive
region was within its C-terminal residues 105–334. Point muta-
tions within these regions blocked their interaction (Zhang et al.,
1999). SOCS3 was discovered for its ability to inhibit tyrosine
phosphorylation of STAT3 through binding to gp130 and JAKs
(Krebs and Hilton, 2001). It has subsequently been shown that
endogenousSOCS3canalsoinhibitAP-1activitybyblockingJNK
phosphorylation(Miaoetal.,2008).ThereforeSOCS3couldbean
importantmoleculeregulatingaxonalregenerationbycontrolling
changes in JNK and JAK/STAT signaling pathways after injury.
Additional transcription factors encompassing a compen-
satory/complementary role include the C/EBP family members
C/EBPβ and C/EBPδ. The promoter region of a c-Jun coactivator,
an oncogene Jab1, contains binding sequences for C/EBP, GATA,
as well as a STAT3 consensus sequence overlapping the C/EBP
site. Both, mutation of the C/EBP binding site and inhibition of
STAT3, signiﬁcantly reduced Jab1-promoter activity (Shackleford
et al., 2011). C/EBPβ is essential for appropriate induction and
maintenance of GAP-43 mRNA following axonal injury (Nadeau
et al.,2005). While there is no evidence of a direct binding site for
C/EBP on the GAP-43 gene, it contains a functionally important
AP-1siteforc-Junandc-fos(WeberandSkene,1998).C/EBPβcan
bind to and regulate both c-fos and c-Jun (Nadeau et al., 2005),
suggesting a coordinated induction of GAP-43 by C/EBPβ, c-fos,
and c-Jun in injured neurons. It has already been shown that co-
expression of c-Fos with c-Jun induces a greater number of cells
to produce neurites than c-Jun alone (Leppa et al., 1998).
Wehavealreadydiscussedanumberofdifferentstudiesinvesti-
gatingthecomplexassociationbetweenATF3andc-Junexpression
after injury. Besides interacting with leucine zipper transcription
factors, ATF3 can also interact with other transcription factors
upregulated after peripheral injury, such as, STAT3. This could
be via co-activators or by synergistic binding to adjacent DNA
binding sites. For example, SPRR1A, a target gene for ATF3, is a
gp130 pathway protein and its promoter region contains func-
tional AP-1 binding sites (Sark et al., 1998; Pradervand et al.,
2004). The levels of SPRR1A expression in DRGs of injured
wild-type mice are higher than in DRGs of non-injured trans-
genic mice expressing constitutively active ATF3, suggesting that
other downstream signals in addition to ATF3 are likely to govern
SPRR1Aexpression.C/EBPβ,forexample,isinducedafterperiph-
eral nerve injury (Nadeau et al., 2005) and a functional C/EBPβ
bindingsiteislocatedontheSPRR1Apromoter(Pradervandetal.,
2004).Recently,transcriptionofDINE(damage-inducedneuronal
endopeptidase), an enzyme involved in terminal nerve branching
(Nagata et al., 2010), was shown to be increased 60-fold by Sp1
mediated recruitment of STAT3, c-Jun, and ATF3 to the DINE
promoter in response to LIF upregulation and NGF withdrawal
following injury (Kiryu-Seo et al.,2008).
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Nuclear factor kappa-light-chain-enhancer of activated B cell
can also interact with Jun, ATF, CREB, and Fos transcription fac-
tors. STAT3 can induce the alternative NF-κB pathway, and bind
to DNA in a complex with p52, to induce transcription. p53 can
also interact with p52 to regulate expression of its target genes
(reviewed by Perkins, 2007).
Mathematical models of interacting signaling pathways have
been developed to predict regenerative outcomes after injury
(Moya et al., 2011).Transgenic animal models with deletion of
multiple signaling streams will be very useful in identiﬁcation of
functional complementary counterparts.
DOWNSTREAM TARGETS OF TRANSCRIPTION FACTORS
Transcription factors rapidly condition the injured nerve and
within 1–4days after injury, the neuronal perikaryon produces a
plethoraof RNA,protein,andglycolipidcomponentswhichplaya
vitalroleinexecutingaxonalregeneration.Downstreamtargetsof
the transcription factors include a vast number of RAGs that may
beinvolvedincell–cellsignaling,axonalgrowthandsprouting,and
activation of the non-neuronal, cellular milieu. Successful axonal
regeneration is accompanied by the appearance of functionally
diverse families of molecules that regulate surface cytoskeletal
interaction.Examplesofregeneration-associatedcytoskeletalfam-
ilies include the GMC family of “integral” membrane proteins –
GAP-43, MARCKS, and CAP23 (Skene and Willard, 1981; Bomze
et al., 2001), microtubule disassembly molecules (e.g., SCG10,
stathmin, CRMP2, and RB3; Iwata et al., 2002; Mori and Morii,
2002),and the Rho GTPase family (RhoA,Rac,Cdc42,and TC10)
members which act as molecular switches regulating cytoskeletal
structure, dynamics, and cell-adhesion (Etienne-Manneville and
Hall,2002).Regeneratingneuronsalsoupregulateadhesionmole-
culeslikeintegrinsα7andβ1(Klossetal.,1999),CD44(Jonesetal.,
2000), galectin-1 (Horie and Kadoya, 2000), β2-microglobulin
(Oliveira et al., 2004), ninjurin (Araki and Milbrandt, 2000), and
gicerin/CD146 (Hiroi et al.,2003). Neurotrophins like BDNF and
GDNF are induced in the distal stump of the injured axons,
and their exogenous application promotes axonal regeneration of
chronically injured neurons (Boyd and Gordon,2003a,b). In vitro
studies have shown that different neuropeptides like substance
P, somatostatin, vasopressin, calcitonin, and alpha-MSH exert a
moderatebutsigniﬁcantneuritegrowthpromotingeffectonCNS
andPNSneurons(NarumiandFujita,1978;BrintonandGruener,
1987;Raivich,2011).Transgenicandpharmacologicalstudieshave
conﬁrmed a similar role in vivo for peptides like galanin (Holmes
et al., 2000; Wynick et al., 2001), CGRP (Toth et al., 2009), and
PACAP (Pituitary Adenylate Cyclase Activating Peptide; Kimura
et al.,2003; Suarez et al.,2006;Armstrong et al.,2008).
CONCLUDING REMARKS
Injury to peripheral nerves can occur due to several causes rang-
ing from physical injury and accidental trauma to pathological
conditions and degenerative diseases. Achieving successful regen-
eration and synchronized functional recovery following neural
damage is one of the biggest challenges faced by neuroscientists
and clinicians. Transcription factors are master switches control-
ling the expression of multiple gene programs, and orchestrating
complex axon growth and regenerative responses. Blocking tran-
scription using RNA polymerase II inhibitors at an early stage
after injury inhibits the capacity of dissociated neurons to elon-
gate neurites (Smith and Skene, 1997), highlighting their crucial
role in efﬁcient regeneration after nerve injury. In this review, we
have attempted to summarize the roles of a number of different
transcription factors in peripheral nerve regeneration and their
complex web of interactions. An overview of the observed phe-
notypes following global and cell-type speciﬁc deletions is given
in Table 1. Understanding the molecular mechanisms underlying
nerve regeneration via various regeneration-associated molecules
and their signaling components will not only help to enhance the
speed and speciﬁcity of peripheral regeneration but improve the
success of central axonal regeneration, as well.
REFERENCES
Akira,S.(2000).Rolesof STAT3deﬁned
by tissue-speciﬁc gene targeting.
Oncogene 19, 2607–2611.
Akira,S.,Nishio,Y.,Inoue,M.,Wang,X.
J.,Wei,S.,Matsusaka,T.,Yoshida,K.,
Sudo,T.,Naruto,M.,andKishimoto,
T.(1994).MolecularcloningofAprf,
a novel Ifn-stimulated gene factor-
3 p91-related transcription factor
involved in the gp130-mediated sig-
naling pathway. Cell 77, 63–71.
Arakawa, H. (2005). P53, apoptosis
and axon-guidance molecules. Cell
Death Differ. 12, 1057–1065.
Araki,T.,and Milbrandt,J. (2000). Nin-
jurin2,a novel homophilic adhesion
molecule,isexpressedinmaturesen-
sory and enteric neurons and pro-
motes neurite outgrowth. J. Neu-
rosci. 20, 187–195.
Arguni, E., Arima, M., Tsuruoka, N.,
Sakamoto, A., Hatano, M., and
Tokuhisa, T. (2006). JunD/AP-1 and
STAT3arethemajorenhancermole-
culesforhighBcl6expressioninger-
minal center B cells. Int. Immunol.
18, 1079–1089.
Armstrong, B. D., Abad, C., Chhith,
S., Cheung-Lau, G., Hajji, O. E.,
Nobuta, H., and Waschek, J. A.
(2008). Impaired nerve regenera-
tion and enhanced neuroinﬂam-
matory response in mice lack-
ing pituitary adenylyl cyclase acti-
vating peptide. Neuroscience 151,
63–73.
Arthur-Farraj, P., Baskaran, A., Parkin-
son, D., Turmaine, M., Feltri, M.,
Wrabetz, L., Behrens, A., Mirsky,
R., and Jessen, K. (2007). Schwann
cells without c-Jun show retarded
demyelination and dedifferentiation
after peripheral nerve injury. Abstr.
Soc. Neurosci. 480.
Bacon, A., Kerr, N. C. H., Holmes,
F. E., Gaston, K., and Wynick,
D. (2007). Characterization of an
enhancer region of the galanin gene
that directs expression to the dorsal
root ganglion and confers respon-
siveness to axotomy. J. Neurosci. 27,
6573–6580.
Bareyre, F. M., Garzorz, N., Lang, C.,
Misgeld, T., Buning, H., and Ker-
schensteiner, M. (2011). In vivo
imaging reveals a phase-speciﬁc role
of STAT3duringcentralandperiph-
eral nervous system axon regenera-
tion.Proc.Natl.Acad.Sci.U.S.A.108,
6282–6287.
Barnat,M.,Enslen,H.,Propst,F.,Davis,
R. J., Soares, S., and Nothias, F.
(2010). Distinct roles of c-Jun N-
terminal kinase isoforms in neu-
rite initiation and elongation during
axonal regeneration. J. Neurosci. 30,
7804–7816.
Behrens, A., Sibilia, M., and Wag-
ner, E. F. (1999). Amino-terminal
phosphorylation of c-Jun regu-
lates stress-induced apoptosis and
cellularproliferation.Nat.Genet.21,
326–329.
Berdan, R. C., Easaw, J. C., and Wang,
R. (1993). Alterations in mem-
brane potential after axotomy at
different distances from the soma
of an identiﬁed neuron and the
effect of depolarization on neu-
rite outgrowth and calcium chan-
nel expression. J. Neurophysiol. 69,
151–164.
Bergsland, M., Werme, M., Malewicz,
M., Perlmann, T., and Muhr, J.
(2006). The establishment of neu-
ronal properties is controlled by
Sox4 and Sox11. Genes Dev. 20,
3475–3486.
Bermingham, J. R., Scherer, S. S.,
O’Connell, S., Arroyo, E., Kalla, K.
A.,Powell,F.L.,andRosenfeld,M.G.
(1996).Tst-1/Oct-6/SCIPregulatesa
unique step in peripheral myelina-
tion and is required for normal res-
piration. Genes Dev. 10, 1751–1762.
Frontiers in Molecular Neuroscience www.frontiersin.org February 2012 | Volume 5 | Article 8 | 10Patodia and Raivich Transcription factors and regeneration
Besirli, C. G., Wagner, E. F., and John-
son, E. M. (2005). The limited
role of NH2-terminal c-Jun phos-
phorylation in neuronal apoptosis:
identiﬁcation of the nuclear pore
complex as a potential target of
the JNK pathway. J. Cell Biol. 170,
401–411.
Björkblom, B., Ostman, N., Hongisto,
V., Komarovski, V., Filén, J. J.,
Nyman,T.A.,Kallunki,T.,Courtney,
M. J., and Coffey, E. T. (2005). Con-
stitutively active cytoplasmic c-Jun
N-terminal kinase 1 is a dominant
regulator of dendritic architecture:
role of microtubule-associated pro-
t e i n2a sa ne f f e c t o r .J. Neurosci. 25,
6350–6361.
Boeshore, K. L., Schreiber, R. C., Vac-
cariello, S. A., Sachs, H. H., Salazar,
R., Lee, J., Ratan, R. R., Leahy, P.,
and Zigmond, R. E. (2004). Novel
changesingeneexpressionfollowing
axotomy of a sympathetic ganglion:
a microarray analysis. J. Neurobiol.
59, 216–235.
Bogoyevitch,M.A.,andKobe,B.(2006).
Uses for JNK: the many and varied
substrates of the c-Jun N-terminal
kinases.Microbiol.Mol.Biol.Rev.70,
1061–1095.
Bohatschek, M., Kloss, C. U., Hris-
tova, M., Pfeffer, K., and Raivich, G.
(2004). Microglial major histocom-
patibility complex glycoprotein-1 in
theaxotomizedfacialmotornucleus:
regulation and role of tumor necro-
sis factor receptors 1 and 2. J. Comp.
Neurol. 470, 382–399.
Bomze, H. M., Bulsara, K. R., Iskan-
dar, B. J., Caroni, P., and Skene, J.
H. P. (2001). Spinal axon regenera-
tionevokedbyreplacingtwogrowth
cone proteins in adult neurons. Nat.
Neurosci. 4, 38–43.
Bonilla, I. E., Tanabe, K., and Strittmat-
ter, S. M. (2002). Small proline-rich
repeat protein 1A is expressed by
axotomized neurons and promotes
axonal outgrowth. J. Neurosci. 22,
1303–1315.
Bosse, F., Hasenpusch-Theil, K., Kury,
P., and Muller, H. W. (2006). Gene
expression proﬁling reveals that
peripheral nerve regeneration is a
consequence of both novel injury-
dependent and reactivated develop-
mental processes. J. Neurochem. 96,
1441–1457.
Bosse, F., Kury, P., and Muller, H. W.
(2001). Gene expression proﬁling
and molecular aspects in peripheral
nerve regeneration. Restor. Neurol.
Neurosci. 19, 5–18.
Boyd, J. G., and Gordon, T. (2003a).
Glial cell line-derived neurotrophic
factor and brain-derived neu-
rotrophic factor sustain the axonal
regeneration of chronically axo-
tomized motoneurons in vivo. Exp.
Neurol. 183, 610–619.
Boyd, J. G., and Gordon, T. (2003b).
Neurotrophic factors and their
receptorsinaxonalregenerationand
functional recovery after peripheral
nerve injury. Mol. Neurobiol. 27,
277–323.
Brecht, S., Kirchhof, R., Chromik, A.,
Willesen, M., Nicolaus, T., Raivich,
G.,Wessig,J.,Waetzig,V.,Goetz,M.,
Claussen, M., Pearse, D., Kuan, C.
Y., Vaudano, E., Behrens, A., Wag-
ner,E.,Flavell,R.A.,Davis,R. J.,and
Herdegen,T. (2005). Speciﬁc patho-
physiological functions of JNK iso-
forms in the brain. Eur. J. Neurosci.
21, 363–377.
Brinton, R. E., and Gruener, R.
(1987). Vasopressin promotes neu-
rite growth in cultured embryonic
neurons. Synapse 1, 329–334.
Bromberg, J., and Darnell, J. E. (2000).
The role of STATs in transcrip-
tional control and their impact
on cellular function. Oncogene 19,
2468–2473.
Buchwalter, G., Gross, C., and Wasy-
lyk, B. (2004). Ets ternary com-
plex transcription factors. Gene 324,
1–14.
Cai, D., Deng, K., Mellado, W., Lee,
J., Ratan, R. R., and Filbin, M. T.
(2002). Arginase I and polyamines
act downstream from cyclic AMP
in overcoming inhibition of axonal
growth MAG and myelin in vitro.
Neuron 35, 711–719.
Cimica, V., Chen, H. C., Iyer, J. K., and
Reich,N.C.(2011).Dynamicsof the
STAT3 transcription factor: nuclear
import dependent on Ran and
importin-β1. PLoS ONE 6, e20188.
doi:10.1371/journal.pone.0020188
Coffer, P., Lutticken, C., Vanpuijen-
broek,A.,Klopdejonge,M.,Horn,F.,
and Kruijer, W. (1995). Transcrip-
tional regulation of the Jun b pro-
moter – analysis of STAT-mediated
signal-transduction. Oncogene 10,
985–994.
Costigan,M.,Befort,K.,Karchewski,L.,
Grifﬁn, R. S., D’Urso, D., Allchorne,
A., Sitarski, J., Mannion, J. W., Pratt,
R. E., and Woolf, C. J. (2002).
Replicate high-density rat genome
oligonucleotide microarrays reveal
hundreds of regulated genes in the
dorsal root ganglion after peripheral
nerve injury. BMC Neurosci. 3, 16.
doi:10.1186/1471-2202-3-16
Cox, L. J., Hengst, U., Gurskaya, N. G.,
Lukyanov, K. A., and Jaffrey, S. R.
(2008). Intra-axonal translation and
retrograde trafﬁcking of CREB pro-
motes neuronal survival. Nat. Cell
Biol. 10, 149–159.
Crocker, S. J., Hayley, S. P., Smith,
P. D., Mount, M. P., Lamba, W.
R., Callaghan, S. M., Slack, R. S.,
and Park, D. S. (2006). Regulation
of axotomy-induced dopaminergic
neuron death and c-Jun phospho-
rylation by targeted inhibition of
cdc42 or mixed lineage kinase. J.
Neurochem. 96, 489–499.
Culmsee, C., and Mattson, M. P.
(2005). p53 in neuronal apopto-
sis. Biochem. Biophys. Res. Commun.
331, 761–777.
De-Fraja, C., Conti, L., Magrassi, L.,
Govoni, S., and Cattaneo, E. (1998).
Members of the JAK/STAT pro-
teins are expressed and regulated
during development in the mam-
malianforebrain.J.Neurosci.Res.54,
320–330.
Deng,J.,Zhang,X.L.,Wang,J.W.,Teng,
L. L., Ge, J., Takeiviori, H., Xiong, Z.
Q., and Zhou, Y. (2009). Expression
and regulated nuclear transport of
transducers of regulated Creb 1 in
retinal ganglion cells. Neuroscience
159, 1023–1031.
Di Giovanni, S., Knights, C. D., Rao,
M., Yakovlev, A., Beers, J., Catania,
J., Avantaggiati, M. L., and Faden,
A. I. (2006). The tumor suppressor
protein p53 is required for neurite
outgrowth and axon regeneration.
EMBO J. 25, 4084–4096.
Dobrea, G. M., Unnerstall, J. R., and
Rao, M. S. (1992). The expression
of CNTF message and immunore-
activityinthecentralandperipheral
nervous system of the rat. Brain Res.
Dev. Brain Res. 66, 209–219.
Doyle, C. A., and Hunt, S. P. (1997).
Reduced nuclear factor kappa B
(p65) expression in rat primary sen-
sory neurons after peripheral nerve
injury. Neuroreport 8, 2937–2942.
Dubový, P. (2011). Wallerian degenera-
tionandperipheralnerveconditions
for both axonal regeneration and
neuropathic pain induction. Ann.
Anat. 193, 267–275.
Ducret, C., Maira, S. M., Lutz, Y.,
and Wasylyk, B. (2000). The ternary
complexfactorNetcontainstwodis-
tinctelementsthatmediatedifferent
responses to MAP kinase signalling
cascades. Oncogene 19, 5063–5072.
Dziennis, S., and Alkayed, N. J. (2008).
Role of signal transducer and acti-
vator of transcription 3 in neuronal
survival and regeneration. Rev. Neu-
rosci. 19, 341–361.
Elde, R., Cao, Y. H., Cintra, A., Brelje,
T. C., Pelto-Huikko, M., Junttila, T.,
Fuxe, K., Pettersson, R. F., and Hök-
felt,T.(1991).Prominentexpression
of acidic ﬁbroblast growth factor in
motor and sensory neurons. Neuron
7, 349–364.
Etienne-Manneville, S., and Hall, A.
(2002). Rho GTPases in cell biology.
Nature 420, 629–635.
Faggioli, L., Costanzo, C., Donadelli,
M.,and Palmieri,M. (2004).Activa-
tion of the interleukin-6 promoter
by a dominant negative mutant of
c-Jun. Biochim. Biophys. Acta 1692,
17–24.
Gao, Q., Wolfgang, M. J., Neschen, S.,
Morino,K.,Horvath,T.L.,Shulman,
G.I.,andFu,X.Y.(2004).Disruption
of neural signal transducer and acti-
vator of transcription 3 causes obe-
sity,diabetes,infertility,and thermal
dysregulation. Proc. Natl. Acad. Sci.
U.S.A. 101, 4661–4666.
Gautron,L.,de Smedt-Peyrusse,V.,and
Laye, S. (2006). Characterization of
STAT3-expressing cells in the post-
natal rat brain. Brain Res. 1098,
26–32.
Gresa-Arribas, N., Serratosa, J., Saura,
J., and Sola, C. (2010). Inhibition
of CCAAT/enhancer binding pro-
tein delta expression by chrysin
in microglial cells results in anti-
inﬂammatory and neuroprotective
effects. J. Neurochem. 115, 526–536.
Gutierrez, H., O’Keeffe, G. W., Gavalda,
R., Gallagher, D., and Davies, A. M.
(2008). Nuclear factor kappa B sig-
naling either stimulates or inhibits
neurite growth depending on the
phosphorylation status of p65/RelA.
J. Neurosci. 28, 8246–8256.
Haas,C.A.,Hofmann,H.D.,andKirsch,
M.(1999).ExpressionofCNTF/LIF-
receptor components and activation
of STAT3 signaling in axotomized
facial motoneurons: evidence for
a sequential postlesional function
of the cytokines. J. Neurobiol. 41,
559–571.
Habecker, B. A., Sachs, H. H., Rohrer,
H., and Zigmond, R. E. (2009).
The dependence on gp130 cytokines
of axotomy induced neuropeptide
expressioninadultsympatheticneu-
rons. Dev. Neurobiol. 69, 392–400.
Haeusgen, W., Boehm, R., Zhao, Y.,
Herdegen,T.,andWaetzig,V.(2009).
Speciﬁc activities of individual c-
Jun N-terminal kinases in the brain.
Neuroscience 161, 951–959.
Hai, T., and Curran, T. (1991). Cross-
family dimerization of transcription
factors fos, Jun and atf creb alters
DNA-binding speciﬁcity. Proc. Natl.
Acad. Sci. U.S.A. 88, 3720–3724.
Hai, T., and Hartman, M. G. (2001).
The molecular biology and nomen-
clature of the activating transcrip-
tion factor/cAMP responsive ele-
mentbindingfamilyoftranscription
factors: activating transcription fac-
tor proteins and homeostasis. Gene
273, 1–11.
Frontiers in Molecular Neuroscience www.frontiersin.org February 2012 | Volume 5 | Article 8 | 11Patodia and Raivich Transcription factors and regeneration
Hannila, S. S., and Filbin, M. T. (2008).
The role of cyclic AMP signaling in
promotingaxonalregenerationafter
spinal cord injury. Exp. Neurol. 209,
321–332.
Hanz, S., Perlson, E., Willis, D., Zheng,
J. Q., Massarwa, R., Huerta, J.
J., Koltzenburg, M., Kohler, M.,
van-Minnen, J., Twiss, J. L., and
Fainzilber, M. (2003). Axoplasmic
importins enable retrograde injury
signaling in lesioned nerve. Neuron
40, 1095–1104.
Heinrich, P. C., Behrmann, I., Haan,
S.,Hermanns,H.M.,Muller-Newen,
G., and Schaper, F. (2003). Prin-
ciples of interleukin (IL)-6-type
cytokine signalling and its regula-
tion. Biochem. J. 374, 1–20.
Herdegen, T., Blume, A., Buschmann,
T., Georgakopoulos, E., Winter, C.,
Schmid, W., Hsieh, T. F., Zimmer-
mann, M., and Gass, P. (1997a).
Expression of activating transcrip-
tion factor-2, serum response fac-
tor and cAMP/Ca response element
bindingproteinintheadultratbrain
followinggeneralizedseizures,nerve
ﬁbre lesion and ultraviolet irradia-
tion. Neuroscience 81, 199–212.
Herdegen, T., Skene, P., and Bahr, M.
(1997b). The c-Jun transcription
factor–bipotentialmediatorofneu-
ronal death, survival and regenera-
tion. Trends Neurosci. 20, 227–231.
Herdegen, T., Claret, F. X., Kallunki,
T., Martin-Villalba, A., Winter, C.,
Hunter, T., and Karin, M. (1998).
LastingN-terminalphosphorylation
of c-Jun and activation of c-Jun
N-terminal kinases after neuronal
injury. J. Neurosci. 18, 5124–5135.
Herdegen, T., Kummer, W., Fiallos, C.
E., Leah, J., and Bravo, R. (1991).
Expressionof C-Jun,Jun-BandJun-
Dproteinsinratnervous-systemfol-
lowing transection of vagus nerve
and cervical sympathetic trunk.
Neuroscience 45, 413–422.
Herdegen, T., and Waetzig, V. (2001).
AP-1 proteins in the adult brain:
facts and ﬁction about effectors of
neuroprotection and neurodegener-
ation. Oncogene 20, 2424–2437.
Higashi, N., Kunimoto, H., Kaneko, S.,
Sasaki, T., Ishii, M., Kojima, H.,
and Nakajima, K. (2004). Cytoplas-
mic c-Fos induced by the YXXQ-
derived STAT3 signal requires the
co-operativeMEK/ERKsignalforits
nuclear translocation. Genes Cells 9,
233–242.
Hiroi,S.,Tsukamoto,Y.,Sasaki,F.,Miki,
N.,andTaira,E.(2003).Involvement
of gicerin, a cell adhesion molecule,
in development and regeneration of
chick sciatic nerve. FEBS Lett. 554,
311–314.
Hol, E. M., Schwaiger, F. W., Werner,
A., Schmitt, A., Raivich, G., and
Kreutzberg, G. W. (1999). Regu-
lation of the LIM-type homeobox
gene islet-1 during neuronal regen-
eration. Neuroscience 88, 917–925.
Holmes, F. E., Mahoney, S., King, V. R.,
Bacon, A., Kerr, N. C., Pachnis, V.,
Curtis,R.,Priestley,J.V.,andWynick,
D.(2000).Targeteddisruptionofthe
galanin gene reduces the number of
sensory neurons and their regener-
ative capacity. Proc. Natl. Acad. Sci.
U.S.A. 97, 11563–11568.
Horie, H., and Kadoya, T. (2000). Iden-
tiﬁcation of oxidized galectin-1 as
an initial repair regulatory factor
after axotomy in peripheral nerves.
Neurosci. Res. 38, 131–137.
Huang, A. M., Rudelius, M., Sharan,
S., McAllister, J. M., Raffeld, M.,
Christenson, L. K., and Sterneck,
E. (2007). The Cebpd (C/EBPdelta)
gene is induced by luteinizing hor-
mones in ovarian theca and inter-
stitial cells but is not essential
for mouse ovary function. PLoS
ONE 2, e1334. doi:10.1371/jour-
nal.pone.0001334
Hunt, D., Hossain-Ibrahim, K., Mason,
M. R., Cofﬁn, R. S., Lieberman, A.
R., Winterbottom, J., and Ander-
son, P. N. (2004). ATF3 upreg-
ulation in glia during Wallerian
degeneration: differential expres-
sion in peripheral nerves and CNS
white matter. BMC Neurosci. 5, 9.
doi:10.1186/1471-2202-5-9
Hyatt Sachs, H., Rohrer, H., and Zig-
mond, R. E. (2010). The condi-
tioning lesion effect on sympathetic
neurite outgrowth is dependent on
gp130 cytokines. Exp. Neurol. 223,
516–522.
Hyatt Sachs, H., Schreiber, R. C., Shoe-
maker, S. E., Sabe, A., Reed, E.,
and Zigmond, R. E. (2007). Activat-
ing transcription factor 3 induction
in sympathetic neurons after axo-
tomy: response to decreased neu-
rotrophin availability. Neuroscience
150, 887–897.
Iwata, T., Namikawa, K., Honma, M.,
Mori, N., Yachiku, S., and Kiyama,
H. (2002). Increased expression of
mRNAs for microtubule disassem-
bly molecules during nerve regener-
ation. Brain Res. Mol. Brain Res. 102,
105–109.
Jacobs,W. B., Kaplan, D. R., and Miller,
F. D. (2006). The p53 family in ner-
vous system development and dis-
ease. J. Neurochem. 97, 1571–1584.
Jaegle, M., and Meijer, D. (1998). Role
of Oct-6inSchwanncelldifferentia-
tion.Microsc.Res.Tech.41,372–378.
Jankowski, M. P., Cornuet, P. K., McIL-
wrath,S.,Koerber,H. R.,andAlbers,
K. M. (2006). SRY-box containing
gene 11 (Sox11) transcription factor
is required for neuron survival and
neurite growth. Neuroscience 143,
501–514.
Jankowski, M. P., McIlwrath, S. L., Jing,
X. T., Cornuet, P. K., Salerno, K. M.,
Koerber, H. R., and Albers, K. M.
(2009). Sox11 transcription factor
modulatesperipheralnerveregener-
ation in adult mice. Brain Res. 1256,
43–54.
Jiang, J. G., and Zarnegar, R. (1997).
A novel transcriptional regulatory
region within the core promoter of
the hepatocyte growth factor gene
is responsible for its inducibility by
cytokines via the C/EBP family of
transcription factors. Mol. Cell. Biol.
17, 5758–5770.
Jones, L. L., Liu, Z., Shen, J., Werner,
A., Kreutzberg, G. W., and Raivich,
G. (2000). Regulation of the cell
adhesionmoleculeCD44afternerve
transection and direct trauma to the
mouse brain. J. Comp. Neurol. 426,
468–492.
Kalla, R., Liu, Z., Xu, S., Koppius, A.,
Imai, Y., Kloss, C. U., Kohsaka,
S., Gschwendtner, A., Möller, J.
C., Werner, A., and Raivich, G.
(2001). Microglia and the early
phase of immune surveillance in the
axotomized facial motor nucleus:
impaired microglial activation
and lymphocyte recruitment but
no effect on neuronal survival or
axonal regeneration in macrophage-
colony stimulating factor-
deﬁcient mice. J. Comp. Neurol.
436, 182–201
Kawasaki, T., Oka, N., Tachibana, H.,
Akiguchi, I., and Shibasaki, H.
(2003). Oct6, a transcription fac-
tor controlling myelination, is a
marker for active nerve regenera-
tioninperipheralneuropathies.Acta
Neuropathol. 105, 203–208.
Kenney, A. M., and Kocsis, J. D. (1998).
Peripheral axotomy induces long-
term c-Jun amino-terminal kinase-
1 activation and activator protein-
1 binding activity by c-Jun and
JunD in adult rat dorsal root ganglia
in vivo. J. Neurosci. 18, 1318–1328.
Kerr,N.,Pintzas,A.,Holmes,F.,Hobson,
S. A., Pope, R., Wallace, M., Wasy-
lyk, C., Wasylyk, B., and Wynick, D.
(2010). The expression of ELK tran-
scriptionfactorsinadultDRG:novel
isoforms, antisense transcripts and
upregulation by nerve damage. Mol.
Cell. Neurosci. 44, 165–177.
Kfoury, N., and Kapatos, G. (2009).
Identiﬁcation of neuronal target
genes for CCAAT/enhancer bind-
ing proteins. Mol. Cell. Neurosci. 40,
313–327.
Kimura, H., Kawatani, M., Ito, E., and
Ishikawa, K. (2003). Effects of pitu-
itary adenylate cyclase-activating
polypeptide on facial nerve recovery
in the guinea pig. Laryngoscope 113,
1000–1006.
Kirsch, M., Terheggen, U., and Hof-
mann, H. D. (2003). Ciliary neu-
rotrophic factor is an early lesion-
induced retrograde signal for axo-
tomised facial motoneurons. Mol.
Cell. Neurosci. 24, 130–138.
Kiryu-Seo, S., Kato, R., Ogawa, T., Nak-
agomi,S.,Nagata,K.,andKiyama,H.
(2008). Neuronal injury-inducible
gene is synergistically regulated by
ATF3, c-Jun, and STAT3 through
the interaction with Sp1 in dam-
aged neurons. J. Biol. Chem. 283,
6988–6996.
Kloss, C. U., Werner, A., Klein, M.
A., Shen, J., Menuz, K., Probst, J.
C., Kreutzberg, G. W., and Raivich,
G. (1999). Integrin family of cell
adhesion molecules in the injured
brain: regulation and cellular local-
ization in the normal and regener-
ating mouse facial motor nucleus. J.
Comp. Neurol. 411, 162–178.
Korneev, S., Federov, A., Collins, R.,
Blackshaw, S., and Davies, J. (1997).
A subtractive cDNA library from
an identiﬁed regenerating neuron is
enriched in sequences up-regulated
during nerve regeneration. Invert.
Neurosci. 3, 185–192.
Krebs, D. L., and Hilton, D. J. (2001).
SOCS proteins: negative regulators
of cytokine signalling. Stem Cells 19,
378–387.
Kubo, T., Yamashita, T., Yamaguchi, A.,
Hosokawa, K., and Tohyama, M.
(2002). Analysis of genes induced in
peripheralnerveafteraxotomyusing
cDNA microarrays. J. Neurochem.
82, 1129–1136.
Kuhlbrodt, K., Herbarth, B., Sock, E.,
Enderich, J., Hermans-Borgmeyer,
I.,andWegner,M. (1998). Coopera-
tive function of POU proteins and
SOX proteins in glial cells. J. Biol.
Chem. 273, 16050–16057.
Kury,P.,Abankwa,D.,Kruse,F.,Greiner-
Petter, R., and Muller, H. W. (2004).
Gene expression proﬁling reveals
multiple novel intrinsic and extrin-
sic factors associated with axonal
regenerationfailure.Eur.J.Neurosci.
19, 32–42.
Latouche,M.,Wilton,D.,Arthur-Farraj,
P.,DaCosta,C.,Mitter,R.,Turmaine,
M., Raivich, G., Behrens,A., Mirsky,
R.,andJessen,K.R.(2009).Schwann
cell c-Jun regulates glial support for
survivalof PNSneuronsafterinjury.
Glia 57, S158.
Lavin, M. F., and Gueven, N. (2006).
The complexity of p53 stabilization
Frontiers in Molecular Neuroscience www.frontiersin.org February 2012 | Volume 5 | Article 8 | 12Patodia and Raivich Transcription factors and regeneration
and activation. Cell Death Differ. 13,
941–950.
Lee, N., Neitzel, K. L., Devlin, B. K.,
andMacLennan,A.J.(2004).STAT3
phosphorylation in injured axons
before sensory and motor neuron
nuclei: potential role for STAT3
as a retrograde signaling transcrip-
tion factor. J. Comp. Neurol. 474,
535–545.
Leppa, S., Saffrich, R., Ansorge, W.,
and Bohmann, D. (1998). Differen-
tial regulation of c-Jun by ERK and
JNK during PC12 cell differentia-
tion. EMBO J. 17, 4404–4413.
Leu, J. I., Crissey, M. A. S., Leu, J. P.,
Ciliberto, G., and Tau, R. (2001).
Interleukin-6-induced STAT3 and
AP-1 amplify hepatocyte nuclear
factor 1-mediated transactivation of
hepatic genes, an adaptive response
to liver injury. Mol. Cell. Biol. 21,
414–424.
Levy, D. E., and Lee, C. K. (2002). What
does STAT3 do? J. Clin. Invest. 109,
1143–1148.
Lieberman,A.R.(1971).Theaxonreac-
t i o n–ar e v i e wo ft h ep r incipal
features of perikaryal responses to
axon injury. Int. Rev. Neurobiol. 14,
49–124.
Lim, C. P., and Cao, X. M. (2006).
Structure, function, and regulation
of STAT proteins. Mol. Biosyst. 2,
536–550.
Lindholm, D., Heumann, R., Meyer,
M., and Thoenen, H. (1987).
Interleukin-1 regulates synthesis
of nerve growth-factor in non-
neuronal cells of rat sciatic-nerve.
Nature 330, 658–659.
Lindwall, C., Dahlin, L., Lundborg,
G., and Kanje, M. (2004). Inhi-
bition of c-Jun phosphorylation
reduces axonal outgrowth of adult
rat nodose ganglia and dorsal root
ganglia sensory neurons. Mol. Cell.
Neurosci. 27, 267–279.
Lindwall, C., and Kanje, M. (2005).
Retrograde axonal transport of JNK
signaling molecules inﬂuence injury
induced nuclear changes in p-c-
Jun and ATF3 in adult rat sen-
soryneurons.Mol.Cell.Neurosci.29,
269–282.
Liu, R. Y., and Snider, W. D. (2001).
Different signaling pathways medi-
ate regenerative versus developmen-
tal sensory axon growth. J. Neurosci.
21, RC164.
Lonze, B. E., and Ginty, D. D.
(2002). Function and regulation of
CREB family transcription factors
in the nervous system. Neuron 35,
605–623.
Lonze, B. E., Riccio, A., Cohen, S.,
and Ginty, D. D. (2002). Apop-
tosis, axonal growth defects, and
degeneration of peripheral neurons
in mice lacking CREB. Neuron 34,
371–385.
Ma, V. Y., and Bisby, M. A. (1998).
Increased activation of nuclear fac-
torkappaBinratlumbardorsalroot
ganglion neurons following partial
sciatic nerve injuries. Brain Res.797,
243–254.
Magoulas, B., and Lopez-de Heredia,
L. (2010). Functional analysis of
the transcription factor C/EBPdelta
in neuronal repair. FENS Abstr. 5,
040.12.
Maier, I. C., and Schwab, M. E. (2006).
Sprouting, regeneration and circuit
formationintheinjuredspinalcord:
factors and activity. Philos. Trans.
R. Soc. Lond. B Biol. Sci. 361,
1611–1634.
Makwana,M.,Werner,A.,Acosta-Saltos,
A., Gonitel, R., Pararajasingham, A.,
Ruff, C., Rumajogee, P., Cuthill, D.,
Galiano, M., Bohatschek, M., Wal-
lace, A. S., Anderson, P. N., Mayer,
U., Behrens, A., and Raivich, G.
(2010). Peripheral facial nerve axo-
tomy in mice causes sprouting of
motor axons into perineuronal cen-
tral white matter: time course and
molecularcharacterization.J.Comp.
Neurol. 518, 699–721.
Mandemakers,W.,Zwart,R.,Jaegle,M.,
Walbeehm, E., Visser, P., Grosveld,
F., and Meijer, D. (2000). A dis-
tal Schwann cell-speciﬁc enhancer
mediates axonal regulation of the
Oct-6 transcription factor dur-
ing peripheral nerve development
and regeneration. EMBO J. 19,
2992–3003.
Mason, M. R., Lieberman, A. R.,
and Anderson, P. N. (2003). Cor-
ticospinal neurons up-regulate a
range of growth-associated genes
following intracortical, but not
spinal, axotomy. Eur. J. Neurosci. 18,
789–802.
Mattson, M. P. (2005). NF-kappa B in
the survival and plasticity of neu-
rons. Neurochem. Res. 30, 883–893.
Mayr, B., and Montminy, M. (2001).
Transcriptional regulation by the
phosphorylation-dependent factor
CREB. Nat. Rev. Mol. Cell Biol. 2,
599–609.
Mayumi-Matsuda, K., Kojima, S.,
Nakayama, T., Suzuki, H., and
Sakata, T. (1999). Scanning gene
expression during neuronal cell
death evoked by nerve growth factor
depletion. Biochim. Biophys. Acta
1489, 293–302.
Miao, T., Wu, D. S., Zhang, Y., Bo,
X. N., Subang, M. C., Wang, P.,
and Richardson, P. M. (2006).
Suppressor of cytokine signaling-3
suppresses the ability of activated
signal transducer and activator of
transcription-3 to stimulate neurite
growth in rat primary sensory neu-
rons. J. Neurosci. 26, 9512–9519.
Miao, T. Z., Wu, D. S., Zhang, Y.,
Bo, X. N., Xiao, F., Zhang, X. Y.,
Magoulas, C., Subang, M. C., Wang,
P., and Richardson, P. M. (2008).
SOCS3 suppresses AP-1 transcrip-
tionalactivityinneuroblastomacells
through inhibition of c-Jun N-
terminal kinase. Mol. Cell. Neurosci.
37, 367–375.
Michaelevski,I.,Segal-Ruder,Y.,Rozen-
baum, M., Medzihradszky, K. F.,
Shalem, O., Coppola, G., Horn-
Saban, S., Ben-Yaakov, K., Dagan,
S. Y., Rishal, I., Geschwind, D. H.,
Pilpel, Y., Burlingame, A. L., and
Fainzilber, M. (2010). Signalling to
transcription networks in the neu-
ronalretrogradeinjuryresponse.Sci.
Signal. 3, 1–11.
Moisse,K.,Volkening,K.,Leystra-Lantz,
C., Welch, I., Hill, T., and Strong,
M. J. (2009). Divergent patterns
of cytosolic TDP-43 and neuronal
progranulin expression following
axotomy: implications for TDP-43
in the physiological response to
neuronal injury. Brain Res. 1249,
202–211.
Moore,D.L.,andGoldberg,J.L.(2011).
Multiple transcription factor fami-
lies regulate axon growth and regen-
eration. Dev. Neurobiol. 71, 1186–
1211.
Mori,N.,and Morii,H. (2002). SCG10-
related neuronal growth-associated
proteins in neural development,
plasticity,degeneration,andaging.J.
Neurosci. Res. 70, 264–273.
Morrison,D. K.,and Davis,R. J. (2003).
Regulation of map kinase signal-
ing modules by scaffold proteins in
mammals. A n n u .R e v .C e l lD e v .B i o l .
19, 91–118.
Morton, S., Davis, R. J., McLaren, A.,
and Cohen, P. (2003). A reinves-
tigation of the multisite phospho-
rylation of the transcription factor
c-Jun. EMBO J. 22, 3876–3886.
Moya, C., Huang, Z., Cheng, P., Jayara-
man,A., and Hahn, J. (2011). Inves-
tigation of IL-6 and IL-10 signalling
via mathematical modelling. IET
Syst. Biol. 5, 15–26.
Nadeau, S., Hein, P., Fernandes, K. J.,
Peterson, A. C., and Miller, F. D.
(2005). A transcriptional role for
C/EBPbetaintheneuronalresponse
to axonal injury. Mol. Cell. Neurosci.
29, 525–535.
Nagata, K., Kiryu-Seo, S., Maeda,
M., Yoshida, K., Morita, T., and
Kiyama, H. (2010). Damage-
induced neuronal endopeptidase is
critical for presynaptic formation
of neuromuscular junctions. J.
Neurosci. 30, 6954–6962.
Nakagomi, S., Suzuki, Y., Namikawa,
K., Kiryu-Seo, S., and Kiyama, H.
(2003). Expression of the activat-
ingtranscriptionfactor3preventsc-
JunN-terminalkinase-inducedneu-
ronaldeathbypromotingheatshock
protein 27 expression and Akt acti-
vation. J. Neurosci. 23, 5187–5196.
Narumi, S., and Fujita, T. (1978). Stim-
ulatory effects of substance-P and
nerve growth factor (NGF) on neu-
rite outgrowth in embryonic chick
dorsal root ganglia. Neuropharma-
cology 17, 73–76.
Oliveira, A. L., Thams, S., Lidman,
O., Piehl, F., Hokfelt, T., Karre, K.,
Linda, H., and Cullheim, S. (2004).
A role for MHC class I molecules
in synaptic plasticity and regen-
eration of neurons after axotomy.
Proc. Natl. Acad. Sci. U.S.A. 101,
17843–17848.
Patodia, S., Hristova, M., Makwana,
M., Rumajogee, P., Akira, S., and
Raivich, G. (2011). Transcription
factor STAT3 is required for efﬁ-
cient regeneration after peripheral
nerve injury. Abstr. Soc. Neurosci.
784.01/BB22.
Pearson, A. G., Gray, C. W., Pear-
son, J. F., Greenwood, J. A., During,
M. J., and Dragunow, M. (2003).
ATF3enhancesc-Jun-mediatedneu-
rite sprouting. Brain Res. Mol. Brain
Res. 120, 38–45.
Perkins, N. D. (2007). Integrating cell-
signalling pathways with NF-kappa
B and IKK function. Nat. Rev. Mol.
Cell Biol. 8, 49–62.
Pollock,G.,Pennypacker,K. R.,Memet,
S., Israel, A., and Saporta, S. (2005).
Activation of NF-kappa B in the
mouse spinal cord following sciatic
nerve transection. Exp. Brain Res.
165, 470–477.
Pradervand, S., Yasukawa, H., Muller,
O. G., Kjekshus, H., Nakamura, T.,
St Amand, T. R., Yajima, T., Mat-
sumura,K.,Duplain,H.,Iwatate,M.,
Woodard, S., Pedrazzini, T., Ross, J.,
Firsov, D., Rossier, B. C., Hoshijima,
M., and Chien, K. R. (2004). Small
proline-rich protein 1A is a gp130
pathway- and stress-inducible car-
dioprotective protein. EMBO J. 23,
4517–4525.
Qin,Q.Y.,Baudry,M.,Liao,G.H.,Non-
iyev, A., Galeano, J., and Bi, X. N.
(2009). A novel function for p53:
regulation of growth cone motility
throughInteractionwithrhokinase.
J. Neurosci. 29, 5183–5192.
Raivich, G. (2008). c-Jun expression,
activationandfunctioninneuralcell
death, inﬂammation and repair. J.
Neurochem. 107, 898–906.
Frontiers in Molecular Neuroscience www.frontiersin.org February 2012 | Volume 5 | Article 8 | 13Patodia and Raivich Transcription factors and regeneration
Raivich, G. (2011). Transcribing the
path to neurological recovery-from
early signals through transcription
factors to downstream effectors of
successful regeneration. Ann. Anat.
193, 248–258.
Raivich,G.,andBehrens,A.(2006).Role
of the AP-1 transcription factor c-
Jun in developing,adult and injured
brain. Prog. Neurobiol. 78, 347–363.
Raivich, G., Bohatschek, M., Da Costa,
C., Iwata, O., Galiano, M., Hris-
tova,M.,Nateri,A.S.,Makwana,M.,
Riera-Sans, L., Wolfer, D. P., Lipp,
H. P., Aguzzi, A., Wagner, E. F., and
Behrens, A. (2004). The AP-1 tran-
scription factor c-Jun is required for
efﬁcient axonal regeneration. Neu-
ron 43, 57–67.
Raivich,G.,Hellweg,R.,andKreutzberg,
G. W. (1991). NGF receptor-
mediated reduction in axonal NGF
uptake and retrograde transport
following sciatic nerve injury and
during regeneration. Neuron 7,
151–164.
Raivich, G., Jones, L. L., Kloss, C.
U., Werner, A., Neumann, H., and
Kreutzberg, G. W. (1998). Immune
surveillance in the injured ner-
vous system: T-lymphocytes invade
the axotomized mouse facial motor
nucleus and aggregate around sites
of neuronal degeneration. J. Neu-
rosci. 18, 5804–5816.
Ram, P. T., and Iyengar, R. (2001). G
protein coupled receptor signaling
throughtheSrcandSTAT3pathway:
roleinproliferationandtransforma-
tion. Oncogene 20, 1601–1606.
Ramji, D. P., and Foka, P. (2002).
CCAAT/enhancer-binding proteins:
structure, function and regulation.
Biochem. J. 365, 561–575.
Ramji, D. P., Vitelli, A., Tronche, F.,
Cortese,R.,andCiliberto,G.(1993).
The2c/EBPisoforms,IL-6DBP/NF-
IL6 and c/EBP-delta/NF-IL6 beta,
areinducedbyIL-6topromoteacute
phase gene-transcription via differ-
ent mechanisms. Nucleic Acids Res.
21, 289–294.
Redmond, L., Kashani, A. H., and
Ghosh, A. (2002). Calcium reg-
ulation of dendritic growth
via CaM kinase IV and CREB-
mediated transcription. Neuron 34,
999–1010.
Rende,M.,Muir,D.,Ruoslahti,E.,Hagg,
T., Varon, S., and Manthorpe, M.
(1992). Immunolocalization of cil-
iary neuronotrophic factor in adult
rat sciatic nerve. Glia 5, 25–32.
Rudolph, D., Tafuri, A., Gass, P., Ham-
merling, G., Arnold, B., and Schutz,
G. (1998). Impaired fetal T cell
development and perinatal lethality
in mice lacking the cAMP response
element binding protein. Proc. Natl.
Acad. Sci. U.S.A. 95, 4481–4486.
Ruff, C., Da Costa, C., Staak, N., Ruma-
jogee, P., Makwana, M., Acosta-
Saltos, A., Kaswich, M., Brecht, S.,
Hristova, M., Riera-Sans, L., Mirsky,
R.,Herdegen,T.,Jessen,K.,Behrens,
A., and Raivich, G. (2009). The role
of c-Jun and its N-terminal phos-
phorylationinfacialnerveregenera-
tion. Abstr. Soc. Neurosci. 510.9/B42.
Sark, M. W. J., Fischer, D. F., de Meijer,
E., van de Putte, P., and Backendorf,
C.(1998).AP-1andetstranscription
factorsregulatetheexpressionof the
human SPRR1A keratinocyte termi-
nal differentiation marker. J. Biol.
Chem. 273, 24683–24692.
Sato, T., Takeuchi, S., Saito, A., Ding,
W., Bamba, H., Matsuura, H., Hisa,
Y., Tooyama, I., and Urushitani,
M. (2009). Axonal ligation induces
transient redistribution of TDP-43
in brainstem motor neurons. Neu-
roscience 164, 1565–1578.
Sauer, B. (1998). Inducible gene target-
inginmiceusingtheCre/loxsystem.
Methods 14, 381–392.
Schaefer, T. S., Sanders, L. K., and
Nathans, D. (1995). Cooperative
transcriptional activity of Jun and
STAT3-beta,a short-form of STAT3.
Proc. Natl. Acad. Sci. U.S.A. 92,
9097–9101.
Scherer, S. S., Wang, D. Y., Kuhn,
R., Lemke, G., Wrabetz, L., and
Kamholz, J. (1994). Axons regulate
Schwann-cell expression of the pou
transcriptionfactorScip.J.Neurosci.
14, 1930–1942.
Schmied, R., Huang, C. C., Zhang, X.
P., Ambron, D. A., and Ambron,
R. T. (1993). Endogenous axoplas-
mic proteins and proteins con-
taining nuclear localization signal
sequences use the retrograde axonal
transport/nuclear import pathway
in Aplysia neurons. J. Neurosci. 13,
4064–4071.
Schwaiger, F. W., Hager, G., Schmitt,
A. B., Horvat, A., Hager, G., Streif,
R., Spitzer, C., Gamal, S., Breuer, S.,
Brook, G. A., Nacimiento, W., and
Kreutzberg, G. W. (2000). Periph-
eralbutnotcentralaxotomyinduces
changes in Janus kinases (JAK) and
signal transducers and activators of
transcription (STAT). Eur. J. Neu-
rosci. 12, 1165–1176.
Schwarz, C. S., Seyfried, J., Evert, B.
O., Klockgether, T., and Wullner,
U. (2002). Bcl-2 up-regulates ha-ras
mRNA expression and induces c-
Jun phosphorylation at Ser73 via an
ERK-dependent pathway in PC 12
cells. Neuroreport 13, 2439–2442.
Schweizer, U., Gunnersen, J., Karch, C.,
Wiese, S., Holtmann, B., Takeda, K.,
Akira, S., and Sendtner, M. (2002).
Conditional gene ablation of STAT3
revealsdifferentialsignalingrequire-
ments for survival of motoneurons
during development and after nerve
injury in the adult. J. Cell Biol. 156,
287–297.
Seijffers, R.,Allchorne,A. J., and Woolf,
C. J. (2006). The transcription fac-
tor ATF-3 promotes neurite out-
growth. Mol. Cell. Neurosci. 32,
143–154.
Seijffers, R., Mills, C. D., and Woolf, C.
J. (2007). ATF3 increases the intrin-
sic growth state of DRG neurons to
enhance peripheral nerve regenera-
tion. J. Neurosci. 27, 7911–7920.
Sendtner, M., Gotz, R., Holtmann, B.,
Escary, J. L., Masu, Y., Carroll, P.,
Wolf, E., Brem, G., Brulet, P., and
Thoenen,H.(1996).Crypticphysio-
logical trophic support of motoneu-
rons by LIF revealed by double gene
targeting of CNTF and LIF. Curr.
Biol. 6, 686–694.
Sendtner, M., Gotz, R., Holtmann, B.,
and Thoenen, H. (1997). Endoge-
nous ciliary neurotrophic factor
is a lesion factor for axotomized
motoneurons in adult mice. J. Neu-
rosci. 17, 6999–7006.
Shackleford, T. J., Zhang, Q., Tian, L.,
Vu, T. T., Korapati, A. L., Baum-
gartner, A. M., Le, X. F., Liao,
W. S., and Claret, F. X. (2011).
STAT3 and CCAAT/enhancer bind-
ing protein beta (C/EBP-beta) regu-
late Jab1/CSN5 expression in mam-
mary carcinoma cells. Breast Cancer
Res. 13, R65.
Skene, J. H. P., and Willard, M. (1981).
Characteristicsof growth-associated
polypeptides in regenerating toad
retinal ganglion-cell axons. J. Neu-
rosci. 1, 419–426.
Smith, D. S., and Skene, J. H. P. (1997).
A transcription-dependent switch
controls competence of adult neu-
rons for distinct modes of axon
growth. J. Neurosci. 17, 646–658.
Sole, C., Dolcet, X., Segura, M. F.,
Gutierrez, H., Diaz-Meco, M. T.,
Gozzelino, R., Sanchis, D., Bayascas,
J. R., Gallego, C., Moscat, J., Davies,
A.M.,andComella,J.X.(2004).The
deathreceptorantagonistFAIMpro-
motesneuriteoutgrowthbyamech-
anismthatdependsonERKandNF-
kappa B signaling. J. Cell Biol. 167,
479–492.
Suarez, V., Guntinas-Lichius, O., Strep-
pel, M., Ingorokva, S., Grosheva,
M., Neiss, W. F., Angelov, D.
N., and Klimaschewski, L. (2006).
The axotomy-induced neuropep-
tides galanin and pituitary adenylate
cyclase-activating peptide promote
axonalsproutingof primaryafferent
and cranial motor neurones. Eur. J.
Neurosci. 24, 1555–1564.
Sun, F., Park, K. K., Belin, S., Wang, D.,
Lu,T.,Chen,G.,Zhang,K.,Yeung,C.,
Feng, G., Yankner, B. A., and He, Z.
(2011). Sustained axon regeneration
inducedbyco-deletionof PTENand
SOCS3. Nature 480, 372–375.
Sun, P. Q., Enslen, H., Myung, P.
S., and Maurer, R. A. (1994).
Differential activation of Creb
by Ca2+/calmodulin-dependent
protein-kinases type-II and type-IV
involves phosphorylation of a site
that negatively regulates activity.
Genes Dev. 8, 2527–2539.
Sung,Y. J., Povelones, M., and Ambron,
R. T. (2001). RISK-1: a novel MAPK
homologue in axoplasm that is acti-
vated and retrogradely transported
after nerve injury. J. Neurobiol. 47,
67–79.
Symes, A., Gearan, T., Eby, J., and
Fink, J. S. (1997). Integration of
Jak-STAT and AP-1 signaling path-
waysatthevasoactiveintestinalpep-
tide cytokine response element reg-
ulates ciliary neurotrophic factor-
dependent transcription. J. Biol.
Chem. 272, 9648–9654.
Taga, T., and Kishimoto, T. (1995).
Signaling mechanisms through
cytokine receptors that share signal-
transducing receptor components.
Curr. Opin. Immunol. 7, 17–23.
Takeda,K.,Noguchi,K.,Shi,W.,Tanaka,
T., Matsumoto, M., Yoshida, N.,
Kishimoto, T., and Akira, S. (1997).
Targeted disruption of the mouse
STAT3geneleadstoearlyembryonic
lethality. Proc. Natl.Acad. Sci. U.S.A.
94, 3801–3804.
Takeda, M., Kato, H., Takamiya, A.,
Yoshida, A., and Kiyama, H. (2000).
Injury-speciﬁcexpressionof activat-
ing transcription factor-3 in reti-
nal ganglion cells and its colocalized
expression with phosphorylated c-
Jun. Invest. Ophthalmol. Vis. Sci. 41,
2412–2421.
Tanaka, S., Kamachi, Y., Tanouchi, A.,
Hamada, H., Jing, N. H., and Kon-
doh, H. (2004). Interplay of SOX
and POU factors in regulation of
theNestingeneinneuralprimordial
cells. Mol. Cell. Biol. 24, 8834–8846.
Tedeschi, A., Nguyen, T., Puttagunta,
R., Gaub, P., and Di Giovanni, S.
(2009). A p53-CBP/p300 transcrip-
tion module is required for GAP-
43 expression, axon outgrowth, and
regeneration. Cell Death Differ. 16,
543–554.
Topilko, P., Schneidermaunoury, S.,
Levi, G., Baronvanevercooren, A.,
Chennouﬁ, A. B., Seitanidou, T.,
Babinet, C., and Charnay, P. (1994).
Krox-20 controls myelination in the
Frontiers in Molecular Neuroscience www.frontiersin.org February 2012 | Volume 5 | Article 8 | 14Patodia and Raivich Transcription factors and regeneration
peripheral nervous system. Nature
371, 796–799.
Toth, C. C., Willis, D., Twiss, J. L.,
Walsh, S., Martinez, J. A., Liu, W.
Q., Midha, R., and Zochodne, D.
W. (2009). Locally synthesized calci-
toningene-relatedpeptidehasacrit-
ical role in peripheral nerve regen-
eration. J. Neuropathol. Exp. Neurol.
68, 326–337.
Tsujino,H.,Kondo,E.,Fukuoka,T.,Dai,
Y.,Tokunaga,A.,Miki,K.,Yonenobu,
K.,Ochi,T.,and Noguchi,K. (2000).
Activating transcription factor 3
(ATF3) induction by axotomy in
sensory and motoneurons: a novel
neuronal marker of nerve injury.
Mol. Cell. Neurosci. 15, 170–182.
Vries, R. G. J., Prudenziati, M., Zwart-
jes, C., Verlaan, M., Kalkhoven, E.,
and Zantema, A. (2001). A speciﬁc
lysine in c-Jun is required for tran-
scriptional repression by E1A and
is acetylated by p300. EMBO J. 20,
6095–6103.
Waetzig, V., Zhao, Y., and Herdegen, T.
(2006). The bright side of JNKs –
multitalentedmediatorsinneuronal
sprouting, brain development and
nerve ﬁber regeneration. Prog. Neu-
robiol. 80, 84–97.
Waller, A. V. (1850). Experiments on
the section of the glossopharyn-
geal and hypoglossal nerves of the
frog, and observations of the alter-
ationsproducedtherebyinthestruc-
ture of their primitive ﬁbres. Philos.
Trans. R. Soc. Lond. B Biol. Sci. 140,
423–429.
Weber, J. R. M., and Skene, J.
H. P. (1998). The activity of a
highly promiscuous AP-1 element
can be conﬁned to neurons by a
tissue-selectiverepressiveelement.J.
Neurosci. 18, 5264–5274.
Werner, A., Kloss, C. U., Walter, J.,
Kreutzberg, G. W., and Raivich,
G. (1998). Intercellular adhe-
sion molecule-1 (ICAM-1) in
the mouse facial motor nucleus
after axonal injury and during
regeneration. J. Neurocytol. 27,
219–232.
Westerlund, N., Zdrojewska, J., Padzik,
A., Komulainen, E., Björkblom, B.,
Rannikko, E., Tararuk, T., Garcia-
Frigola, C., Sandholm, J., Nguyen,
L., Kallunki, T., Courtney, M. J.,
and Coffey, E. T. (2011). Phospho-
rylationofSCG10/stathmin-2deter-
minesmultipolarstageexitandneu-
ronal migration rate. Nat. Neurosci.
14, 305–313.
Williams, K. L., Rahimtula, M., and
Mearow, K. M. (2006). Heat shock
p r o t e i n2 7i si n v o l v e di nn e u r i t e
extension and branching of dorsal
root ganglion neurons in vitro. J.
Neurosci. Res. 84, 716–723.
Wilton, D., Arthur-Farraj, P., Latouche,
M., Turmaine, M., Behrens, A.,
Mirsky,R.,Raivich,G.,andJessen,K.
(2009). Schwann cell C-Jun is essen-
tial for peripheral nerve regenera-
tion. Glia 57, S158.
Wu, Y. Y., and Bradshaw, R. A.
(1996). Induction of neurite out-
growth by interleukin-6 is accom-
panied by activation of STAT3
signaling pathway in a variant PC12
cell (E2) line. J. Biol. Chem. 271,
13023–13032.
Wynick, D., Thompson, S. W., and
McMahon, S. B. (2001). The role
of galanin as a multi-functional
neuropeptide in the nervous sys-
tem. Curr. Opin. Pharmacol. 1,
73–77.
Xia, X. G., Hofmann, H. D., Deller, T.,
and Kirsch, M. (2002). Induction of
STAT3 signaling in activated astro-
cytes and sprouting septal neurons
followingentorhinalcortexlesionin
adult rats. Mol. Cell. Neurosci. 21,
379–392.
Yang, E., Lerner, L., Besser, D., and
Darnell, J. E. Jr. (2003). Inde-
pendent and cooperative activa-
tion of chromosomal c-fos pro-
moter by STAT3. J. Biol. Chem. 278,
15794–15799.
Yang, Z. Y., Quigley, H. A., Pease, M. E.,
Yang,Y. Q., Qian, J.,Valenta, D., and
Zack, D. J. (2007). Changes in gene
expression in experimental glau-
coma and optic nerve transection:
the equilibrium between protec-
tive and detrimental mechanisms.
Invest. Ophthalmol. Vis. Sci. 48,
5539–5548.
Yoo, S., Nguyen, M. P., Fukuda, M.,
Bittner, G. D., and Fishman, H.
M. (2003). Plasmalemmal sealing
of transected mammalian neurites
is a gradual process mediated by
Ca(2+)-regulated proteins. J. Neu-
rosci. Res. 74, 541–551.
Yoshida, K., Behrens, A., Le-Niculescu,
H., Wagner, E. F., Harada, T., Imaki,
J., Ohno, S., and Karin, M. (2002).
Amino-terminalphosphorylationof
c-Jun regulates apoptosis in the
retinal ganglion cells by optic nerve
transection. Invest. Ophthalmol. Vis.
Sci. 43, 1631–1635.
Zhang, X. K., Wrzeszczynska, M.
H., Horvath, C. M., and Darnell,
J. E. (1999). Interacting regions
in STAT3 and c-Jun that par-
ticipate in cooperative transcrip-
tional activation. Mol. Cell. Biol. 19,
7138–7146.
Zigmond, R. E., and Vaccariello, S.
A. (2007). Activating transcription
factor 3 immunoreactivity iden-
tiﬁes small populations of axo-
tomized neurons in rat cervical
sympathetic ganglia after transec-
tion of the preganglionic cervical
sympathetic trunk. Brain Res. 1159,
119–123.
Conﬂict of Interest Statement: The
authors declare that the research was
conducted in the absence of any com-
mercial or ﬁnancial relationships that
could be construed as a potential con-
ﬂict of interest.
Received: 05 November 2011; accepted:
24 January 2012; published online: 10
February 2012.
Citation:Patodia SandRaivich G(2012)
Role of transcription factors in peripheral
nerveregeneration.Front.Mol.Neurosci.
5:8. doi: 10.3389/fnmol.2012.00008
Copyright © 2012 Patodia and Raivich.
This is an open-access article distributed
underthetermsoftheCreativeCommons
Attribution Non Commercial License,
which permits non-commercial use, dis-
tribution, and reproduction in other
forums,providedtheoriginalauthorsand
source are credited.
Frontiers in Molecular Neuroscience www.frontiersin.org February 2012 | Volume 5 | Article 8 | 15